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Illness representations and psychological well-being were investigated in two patient
groups diagnosed with insulin dependent diabetes; Type 1 diabetic patients, and
patients with diabetes secondary to cystic fibrosis, a pre-existing, life threatening,
genetic condition. The purpose of this study was to compare the illness
representations held by patients to investigate whether differences in perceptions of
consequences and control existed between groups. This study also investigated
whether patients' perceptions of illness played a role in levels of anxiety and
depression and whether differences in illness representations existed between
patients and their health care teams.
Method:
Participants completed self-report questionnaires measuring illness representations of
diabetes and levels of anxiety and depression. All eligible participants were sent the
study pack to their home address by post. A total of 22 cystic fibrosis related
diabetes (CFRD) and 45 Type 1 diabetes patients completed and returned the
questionnaires. Age, duration of diabetes and recent blood glucose level (HbAlc
level) information was obtained for each participant. All participants were over 16
years of age. In addition, a total of 17 staff, working within the adult cystic fibrosis
service completed an adapted version of the Illness Perceptions Questionnaire.
Results & Discussion:
There were no significant differences between the two patient groups on perceived
consequences or treatment control of diabetes. Contrary to prediction, the CFRD
group perceived significantly lower levels of personal control over their diabetes than
the Type 1 group (pc.Ol). This finding may, in part, be due to the CFRD patients'
perception of their diabetes as a largely uncontrollable consequence of the
progression of their cystic fibrosis. No associations were found between illness
representations and levels of anxiety and depression in the CFRD group, however
perceived consequences and treatment control were predictive of levels of
depression, measured by the Well-being Questionnaire, in the Type 1 group
(Adjusted R squared = .208, p = 0.016). Differences existed between the staff group
and the CFRD patient group on perceived consequences of diabetes (<.001) but staff
and patients' beliefs converged on perceived levels of control. Clinical implications




As research into medical illnesses advances and treatments improve, more people are
living with chronic medical conditions, which although cannot be cured, can be
managed with ongoing treatment regimes. In this climate of medical advances,
patients and their families may have increasing expectations that all medical
problems are curable. Given such expectations, accepting the personal consequences
of a chronic medical condition and embracing self-management of illness can be
difficult. The goal in chronic illness (Holman & Lorig, 2000) is not cure, but rather
the maintenance of a pleasurable and independent life for the affected individual.
Improved treatments are leading to prolonged life, but what is the impact of living
with a chronic medical condition on psychological well-being and quality of life?
Inherent in chronic illness is uncertainty, indefinite outcomes and often having to
cope with a dynamic and progressive disease course. The individual with a chronic
condition has to adapt to coping with their illness, a situation that often requires a
significant degree of self-management.
The physical and psychosocial functioning of individuals with the same medical
conditions varies widely, suggesting that there is a huge variation in the subjective
impact of a chronic medical condition. It is generally accepted that 20-25% of
individuals with a chronic medical problem experience significant psychological
symptoms (White, 2000). Contributors to the psychological impact of illness may
include the stigma of ill health, functional limitations and the consequent impact of
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limitations on independence and role, the need for behavioural changes as well as the
negative impact that the problem has on the individual's daily routine.
This variation in subjective impact has been investigated in terms of the ways in
which patients make sense of and respond to the threat carried by their illness. The
Self-Regulation Model developed by Leventhal and colleagues attempts to explain
this variation and proposes a number of stages the individual goes through when
faced with illness (Leventhal, Meyer & Nerenz, 1984). The present study was
interested in this variation in psychological adjustment to chronic illness, specifically
focussing on insulin dependent diabetes, and used Leventhal's model to investigate
the cognitive representations people hold of their illness.
One reason why diabetes has become a target of research in health psychology is
because understanding patients' perspectives on their illness should lead to ways to
foster better self-management (Hampson, 1997). This study will investigate
psychological adjustment and illness representations in individuals with insulin
dependent diabetes but is specifically interested in the relative impact of the
condition on two different patient populations. It compares the psychological well-
being and representations of illness in a group of Type 1 insulin dependent diabetics
with no other medical problems with a group of patients diagnosed, in childhood,
with Cystic Fibrosis (CF), a life-threatening, genetic disease, who have subsequently
developed insulin dependent diabetes as a secondary complication to their CF.
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Psychological adjustment to chronic medical problems is important as it can impact
on the individual in a number of ways; on mood, behavioural responses, disease
course and outcome, and ultimately quality of life, independent of the effects of the
medical disorder. Previous research has shown an increased risk of developing a
depressive illness in individuals with diabetes compared to the general population
(Anderson, et al 2001b) however the impact of a secondary diagnosis of diabetes on
individuals with a pre-existing chronic illness is not yet known. The current study
aimed to investigate this with reference to cystic fibrosis.
1.2 Diabetes Mellitus
Facts and Figures
Diabetes mellitus is a relatively common chronic condition for which there is
currently no known cure. Individuals suffering from diabetes experience elevated
blood sugar levels that need to be controlled with dietary restriction and/or
medication. There are two main forms of diabetes, insulin dependent diabetes
mellitus (IDDM) and non-insulin dependent diabetes mellitus (NIDDM). About 3%
of the adult UK population has a diagnosis of diabetes, of which 10-25% are IDDM
(Diabetes UK, 2003). Internationally, diabetes mellitus is a serious chronic condition
for about 2% of the world population with prevalence expected to rise over the next
decade (Surgenor, Horn, Hudson, Lunt & Tennent, 2000). It is the seventh leading
cause of death in the USA (Hampson, 1997).
Diabetes has stimulated research due to the importance of its self management
regime as well as the reported relatively high risk of developing depression in
9
individual's with diabetes in comparison to the general population (Anderson et al
2001b). Management of diabetes aims to optimise the individual's glycaemic control
in order to avoid short term risks such as seizures and coma as well as to delay or
prevent long-term complication of diabetes i.e. neuropathy, heart disease, renal
disease and retinopathy.
Causes and Complications
IDDM, also known as Type 1 diabetes, usually appears before the age of forty. In
Type 1 diabetes, cells in the pancreas are destroyed resulting in them being unable to
produce any, or sufficient amounts, of the hormone insulin, which is required for the
uptake, storage and release of glucose in the body. Without insulin, the body is
unable to utilise the glucose ingested by the individual or released by the liver,
subsequently the body is unable to turn glucose into the energy the body requires.
As a result, blood glucose levels rise producing hyperglycaemia leading to symptoms
of excessive urination, thirst and weight loss. Complications resulting from
increased blood glucose levels include damage to the kidneys and eyes as well as
increased risk of coronary heart disease, stroke, circulation problems and nerve
damage. If left untreated high glucose levels may lead to coma and eventually death
(Diabetes UK, 2003; Hampson, 1997).
Management
Management of Type 1 Diabetes aims to replace the body's faulty production of
insulin by injecting insulin into the body. People with this type of diabetes
commonly take either two or four injections of insulin each day (Diabetes UK,
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2003). The individual diagnosed with insulin dependent diabetes will be required to
self administer daily insulin injections for the rest of their life. Combined with this,
the individual must monitor their blood glucose levels as well as continuously
manage their diet and exercise. Blood glucose monitoring, involving obtaining a
drop of blood by pricking the finger, should be done at least once a day. The goal of
treatment is to keep blood glucose levels within the normal range, preventing levels
from going high (hyperglycaemia) or dropping too low (hypoglycaemia). Both
hyperglycaemia and hypoglycaemia can have serious consequences if left untreated.
Complications of hyperglycaemia are mentioned above whereas hypoglycaemia, if
left untreated, can cause seizures or coma. Management of diabetes is aimed at
limiting and preventing both the short and long-term complications by keeping blood
glucose levels within a target range i.e. HbAlc <8%.
1.3 Cystic Fibrosis
Facts and Figures
Cystic Fibrosis (CF) is the UK's most common life threatening, inherited, disease. It
affects around 7,500 children and adults in the UK and approximately 1:2500 live
births (Hill & Temple, 1998). The disease is caused by mutations to a single gene,
discovered in 1989, called the Cystic Fibrosis Transmembrane Conductance
Regulator (CFTR) gene, essential for regulating salt and water movements across
cell membranes. Until relatively recently, individuals born with CF were not living
past childhood or early adolescence, however, treatment advances in recent years
have improved life expectancy and now well over half of people born with CF live
beyond the age of 30. The life expectancy of those with CF has increased in many
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countries probably as the result of increased availability of medication, overall
rigorous care and the diagnosis of milder forms of the disease. The early treatment
of newborns screened for CF as well as well-organized CF centres that provide
regular and coordinated care appear to be important elements in the improved care
and survival of patients (WHO, 1994).
Symptoms and Complications
Faulty regulation of salt and water across cell membranes results in people with CF
producing thick, sticky mucus, which clogs the lungs and digestive system making it
difficult for individuals with CF to breathe and absorb food properly. Pulmonary
hypersecretion blocks airways leaving CF patients vulnerable to chronic bacterial
infections and frequent exacerbations. Patients often have repeated or chronic lung
infections requiring intensive antibacterial therapy. In addition, a wide range of
nutritional problems are associated with CF, which can lead to malnutrition in
patients and can result in growth retardation, delayed puberty, pulmonary disorders,
malabsorption, poor immune status and finally the adverse progression of the disease
(WHO, 1994). Symptoms and complications lead to recurrent infection, bronchial
damage and ultimately death from respiratory failure.
Why is a baby born with Cystic Fibrosis?
A baby is born with CF only if both parents are carriers of the defective CF gene. If
both parents are carriers of the defective gene each child born has a one in four
chance of being bom with CF, similarly each child has the same one in four chance
of being perfectly healthy and a two in four chance of being a carrier of the defective
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CF gene. If the child is born a carrier, the child will be perfectly healthy but may
pass the faulty gene onto its own child. In the UK, one person in 25 is a carrier
(Cystic Fibrosis Trust, 2002). This genetic link is illustrated in Figure 1.1. There are
many different mutations of the CF gene, indeed over 1000 different mutations of the
CF gene have been discovered. The variation in the severity of symptoms
experienced by CF patients can be partly explained by the types of mutations they
carry. Seventy-five percent of people with CF in the UK carry two of the most
common gene mutations, AF 508.
Figure 1.1: The genetic aetiology of Cystic Fibrosis
(adapted from Hill & Temple, 1998)
Father Mother
Carrier Carrier
child 1 child 2 child 3 child 4
CF carrier carrier healthy
Management
There is currently no cure for cystic fibrosis, therefore management is aimed at
slowing or preventing the secondary effects of the disease. Chest physiotherapy is
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fundamental to CF management as airway clearance techniques aim to remove the
excess mucus that clogs the lungs and improve ventilation. Production of pancreatic
enzymes, which help to break down food in the digestive system, is deficient in
approximately 90% of patients with CF (Gavin, 1998). Consequently, these patients
are required to take additional enzymes with food to prevent malabsorption. A
variety of oral medications will be given daily, including prophylactic antibiotics to
help fight infections, fat soluble vitamins and often inhalers and nebulizers to use pre
and post physiotherapy sessions.
The effective management of CF is more complex than simply complying with a set
medical regimen. Patients must routinely monitor their symptoms and interpret
changes as a basis for modifying their personal therapy or seeking additional medical
input (Parcel, Swank, Mariotto, Bartholomew, Czyzewski & Sockrider, 1994).
People with CF face a complex and time-consuming daily routine including
physiotherapy, exercise, medication and dietary supplements.
1.4 Cystic Fibrosis related Diabetes (CFRD)
Facts and Figures
With advances in treatment and improved levels of care there has been a resulting
increase in the life expectancy of individuals born with cystic fibrosis. This has
resulted in a corresponding increase in the number of patients developing diabetes as
a secondary complication mainly because insulin production becomes deficient
owing to increasing pancreatic disease. The incidence and prevalence of impaired
glucose tolerance and diabetes in CF patients is difficult to determine due to lack of
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routine monitoring at most CF centres, however, incidence does appear to increase
with age with reports of 43%-50% prevalence in patients with CF aged over 30
(Lanng, Thorsteinsson & Lund-Andersen, 1994a; Moran, et al 1998). The majority
of patients with CFRD are diagnosed at around 18-20 years of age (Azzopardi &
Lowes, 2003; Dodge & Morrison, 1992).
Management
Cystic fibrosis related diabetes is slightly different from Type 1 diabetes as the onset
of symptoms is usually more gradual and ketoacidosis (the acid bodies that result
from the breakdown of body fat when there is insufficient insulin to allow adequate
passage of glucose from the blood into the cells of the body) is rare. However, it
remains important to achieve optimum blood glucose levels in patients with CFRD
as hyperglycaemia may adversely affect weight and pulmonary function and result in
the development of microvascular complications (Azzopardi & Lowes, 2003).
Evidence exists to suggest that the complications of CFRD increase mortality, can
cause deterioration in respiratory and nutritional status and can have a profound
impact on the clinical course and survival of patients (Milla, Warwick & Moran,
2000; Wilson, Kalnins, Stewart, Hamilton, Hanna, Durie & Pencharz, 2000). The
introduction of insulin therapy for these patients has been shown to improve lung
functioning and reverse detrimental decreases in body mass index (Lanng,
Thorsteinsson, Nerup & Koch, 1994b).
Some CF centres now carry out glucose tolerance tests routinely to monitor for
pancreatic insufficiency. An abnormal glucose tolerance test will not automatically
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result in the need for insulin treatment, for example, if nutritional status and weight
are well maintained. However, when insulin therapy is indicated a diagnosis of
CFRD presents patients with an additional burden, as they are required to understand
and adhere to yet another complex and demanding treatment regime. As with Type 1
diabetes, management of CFRD includes regular blood glucose monitoring and the
need for daily insulin injections.
1.5 Chronic illness and distress
Prevalence of Psychological Distress
What evidence exists to indicate a high prevalence of psychological distress among
individuals with physical illness? As previously mentioned, it is widely accepted
that between 20-25% of people with a chronic medical problem experience
significant psychological problems (White, 2000). This figure may be reduced to
around 15% for general medical outpatients (Guthrie, 1996). In addition, it has been
suggested that research studies investigating and reporting on prevalence rates of
psychological morbidity in medical populations may actually underestimate true
values of distress due to the common psychological defence of denial. Denial used
as a coping strategy by people with medical illness may result in blocking out
awareness of the loss or threat imposed by the illness and repressing thoughts and
emotional responses (Nichols, 1984). A recent Scottish Executive Paper, Health in
Scotland (2000), supported these figures stating that around a quarter of medical
patients experience significant levels of anxiety and depression and highlighted the
need for recognition of psychological problems in this population.
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Demands of Chronic Illness
Chronic illness presents individuals with a number of challenges and demands.
Diagnosis of a chronic illness may challenge the individual's views and beliefs about
the world in which they live and it brings with it the challenges of accepting and
adapting to the personal consequences of illness, coping with self-management of the
condition and forming workable relationships with medical and care staff. These
increased demands in combination with limited personal resources can leave patients
vulnerable to psychological problems.
With illness comes the experience of threat, not just in relation to the immediate
problems but also with regard to future concerns. Chronic illness is often
synonymous with uncertainty and this can prove distressing and problematic for
many patients. In addition there is often a lack of control over the situation that
undermines feelings of personal security. The experience of loss both with regard to
the specific consequences of the illness or disease as well as in relation to the loss of
key roles is another common reaction. Personally important and valued
occupational, social and sexual roles can be hard to maintain and can result in
significant psychological distress. Patients may be left feeling isolated and
unsupported. The individual's beliefs and understanding of the world as a safe, fair
and controllable place may be undermined.
Early Psychological Research in Medical Settings
Studies carried out a number of years ago with general hospital patients revealed
high levels of psychological distress. Moffic and Paykel (1975) screened 150
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medical inpatients using the Beck Depression Inventory and concluded an overall
prevalence of clinical depression of 28.7%. Maguire et al (1974) implemented
screening questionnaires with 230 consecutives admission to two medical wards.
Twenty three percent of the sample met criteria for a psychiatric diagnosis. Hawton
(1981) subsequently followed up this sample after 18 months and identified that
about half of the sample recognised as having a psychiatric diagnosis at baseline
remained so during the follow up period.
Psychosocial Adjustment to Chronic Illness
More recent studies have supported these earlier findings and similarly highlighted
the vulnerability of individuals suffering from chronic illnesses to psychological
distress. Findings from one study (Huure & Aro, 2002) focussed on the long term
psychosocial effects of chronic illness suggested that adults with persistent chronic
illness which limited their daily life, reported more depression and lower self-esteem
than healthy controls. Similarly another study found a strong association between
presence of a chronic medical condition and psychological distress (Koopmans &
Lamers, 2000).
Several studies that have focussed on the relationship between chronic illness and
psychological well-being have suggested that chronic illness has an indirect impact
on psychological well-being via the increased demands placed on the individual
(Hough, Brummit & Templin, 1999; Vilhjalmsson, 1998). One study, conducted in
Iceland, suggested that domestic, occupational and financial strains are aggravated
by the presence of a chronic illness that in turn undermines personal resources
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(Vilhjalmsson, 1998). Similarly, results of a study carried out in the United States
(Hough et al, 1999) suggested a model whereby chronic illness had no direct effect
on depression but rather had an indirect impact on the demands of the individual that
led to decreased social support and increased depression.
On the contrary, results have also been reported that found that psychological
adaptation amongst patients with a variety of chronic illnesses, including arthritis,
diabetes, cancer, renal disease and dermatological disorders showed remarkably
effective psychological adaptation and did not differ significantly from the general
population on scores of psychological status (Cassileth, Lusk, Strouse, Miller, Brown
& Cross, 1984). In addition, evidence has been provided that showed that chronic
illness is associated with increased emotional distress and suicidal ideation in
females, but not males (Suris, Parara & Puig, 1996).
Despite conflicting findings, what remains important is that psychological factors in
chronic illness are present and they should not be ignored. The psychological
ramifications of chronic illness are often overlooked as many patients do adjust well
to their situation. However, for others adjustment is not so easy and as Nichols
(1984) emphasised "it is vital to remember that for some the anguish of the
emotional reaction is harder to bear than the illness itself'.
A comprehensive review of the literature on the association between chronic illness
and psychological well-being is beyond the scope of the present study, however the
evidence available provides confirmation that psychological factors in chronic illness
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play a substantial role. The current study is primarily interested in the psychological
adaptation to chronic illness in two specific patient populations, Type 1 diabetes and
cystic fibrosis related diabetes, it is to these groups that we now turn.
Psychosocial adjustment to Cystic Fibrosis
Cystic Fibrosis has a profound impact on both the lives of people with the disease
and their families. The illness is the sum of its physical symptoms as well as its
psychological and social consequences (Aspin, 1991). Researchers who have
investigated the psychosocial adaptation of individuals with CF have found varying
results. Studies interested in childhood adaptation to the disease vary from
conclusions that children with CF are as well adjusted as their healthy peers (Drotar,
Doershuk, Stern, Boat, Boyer & Matthews, 1981; Cappelli, McGrath, Fleick,
MacDonald, Feldman & Rowe, 1989; Kashani, Barbero, Wilfrey, Morris &
Shepperd, 1988) to suggestions that psychiatric diagnosis is more common in
children with CF compared with a healthy control group (Steinhausen & Schindler,
1981) and findings that 53% of a sample of 36 children with CF had a psychiatric
disorder (Steinhauser, Schindler & Stephan, 1983). Another study provided evidence
that although children with cystic fibrosis generally did not demonstrate more
symptoms of psychological disturbance than a comparative healthy group, they did
show levels ofworry, poor self-image and anxiety comparable with that of a group of
psychiatrically referred children (Thompson, Hodges & Hamlett, 1990).
Some of this variation in findings has been put down to methodological limitations,
including the use of small, biased samples, unstandardised questionnaires, the
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absence of comparison groups and inappropriate statistical methods (Lask, 2000). A
meta-analysis carried out by D'Angelo, Fosson and McAninch (1991) concluded that
children with CF were as well adjusted as healthy children and children with other
chronic illnesses. Over recent years, there has been a significant improvement in the
life expectancy of children with CF, resulting in suggestions that the improved
physical ability of younger children with the disease has perhaps altered attitudes and
expectations of these children and their parents contributing to better psychological
adjustment (Norman & Flodson, 1983).
Adolescence is a time of physical, emotional and cognitive growth. Like any other
adolescent, an adolescent with CF must adjust during this time of transition, but in
addition, he/she must also learn to cope with his/her cystic fibrosis. Adapting to CF
in adolescence may involve taking more personal responsibility for treatment and
adapting to the social limitations of the disease. Research focussing on adolescent
adaptation to CF has again generally tended to highlight how well psychologically
adjusted adolescents with CF are (Blair, Cull & Freeman, 1994; Bywater, 1981;
Moise, Drotar, Doershuk & Stern, 1987; Straker & Kuttner, 1980). However,
inconsistencies in the literature are still present; one study (Sawyer, Rosier, Phelan &
Bowes, 1995) concluded that female, but not male, adolescents with CF were
significantly less well adjusted on 11 different measures of self image compared with
healthy controls.
Much of the literature focussing on psychological adjustment to cystic fibrosis has
concentrated on children and adolescents. However, as diagnostic practices improve
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and treatment advances, the life expectancy of individuals born with CF has similarly
improved. Cystic fibrosis is no longer a disease limited to childhood, but presents a
variety of different psychosocial problems for the individual as he/she approaches
adulthood. However, in contrast to the relatively extensive literature focussing on
children and adolescents, there is relatively little research investigating the
psychosocial impact of CF in adulthood. The literature that is available again
provides conflicting evidence. Strauss and Wellisch (1981) found that 43% of their
CF sample were depressed occasionally or frequently and Pearson, Pumariega and
Silheimer (1991) noted a higher prevalence of clinically significant levels of
psychiatric symptoms in their CF sample than would be expected in the general
population. This evidence would suggest that there is a substantial level of
psychological distress in this population. However, in contrast, the finding of
Cowen, Corey, Simmons, Keenan, Robertson & Levison (1984) and Moise et al
(1987) suggested that adults with CF have adequate psychosocial adaptation and
Shepherd, Hovell, Harwood, Granger, Hofstetter and Molgaard (1990) found no
significant differences on four psychosocial measures between their adult CF patients
and a healthy control group. More recent studies carried out in Israel and the US,
have similarly provided evidence of good psychological adaptation in adult CF
populations (Anderson, Flume et al 2001b; Blau, Livne & Mussaffi, 2003).
Psychosocial Adjustment to Diabetes
A diagnosis of diabetes involves patients having to accept the need for a change in
lifestyle and to accommodate to the psychological and behavioural demands of the
illness (Delamater, Jacobson, Anderson, Cox, Fisher & Lustman, 2001; Jacobson,
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1996; White 2000). Patients may find the prospect of the disease and its treatment
daunting due to the daily management regime, the acknowledgement of the risk of
complications and the possibility of later physical health problems. Diagnosis of the
illness presents patients and their families with new challenges and constraints and
for some can lead to a sense of sadness and loss (Jacobson, 1996). In 1989,
representatives of government health departments and patient organizations from all
European countries met in St. Vincent, Italy under the auspice of the World Health
Organisation/International Diabetes Federation. As a result of this meeting
guidelines and recommendations were laid down under the St Vincent Declaration
(Krans, Porta, Keen & Staehr Johansen, 1995), in an attempt to improve both the
clinical and social care of people with diabetes. Included in this declaration were
guidelines to improve the psychological well-being of diabetic patients.
In a recent review (Jacobson, Samson, Weigner & Ryan, 2002) and a meta-analysis
(Anderson et al, 2001a) evidence has been provided that the risk of experiencing
comorbid depression or depressive symptomatology is increased in those individuals
with diabetes compared with the general population. Each presentation of depression
has been shown to have adverse effects on social and physical functioning and on
quality of life, that are independent of the effects of the medical illness (Jacobson et
al, 1997). Anderson et al (2001a) calculated odds ratios to compare the odds of
developing depression in diabetic samples with the odds of developing depression in
non-diabetic samples. Their results concluded that from the 39 studies and combined
total of 20 218 subjects they reviewed, a diagnosis of diabetes doubled the odds of
developing depression. In addition this finding generalized across gender as well as
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community and clinical settings. Aggregate lifetime prevalence of major depression
based on the studies they reviewed was given at 28.5%. This is significantly higher
than the estimate of 17% lifetime prevalence rate of depression in the general
population (Hammen, 2001).
The reason for the increased prevalence of depression in diabetic samples compared
to the general population is not fully understood. Two dominant hypotheses suggest
that either (1) depression occurs directly as a result of the biochemical changes due
to the illness or its treatment, therefore mood disturbance is due to the direct
physiological effects of the medical condition or (2) depression occurs as a result of
the psychological demands or psychological factors related to the illness or its
treatment, suggesting that depression results from the increased stresses and strains
of having a chronic illness, difficulties with adaptation and adjustment to treatment
and often debilitating complications, and the perceived burden/disability of the
illness (Talbot & Nouwen, 2000). Investigation into these hypotheses suggests that
neither is conclusively supported (Talbot & Nouwen, 2000) nor are the two mutually
exclusive. Rather, a complex interaction between genetic, biological, social and
psychological factors is likely to be involved.
Whether the prevalence of depression is higher in diabetics than other individuals
with a chronic illness is questionable. Although a recent study (Kessing, Nilsson,
Siersma & Anderson, 2003) suggested prevalence of depression was not elevated in
people with diabetes compared with other chronic illnesses, this study only compared
diabetic individuals with one other patient group, patients with osteoarthritis, and
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despite very large samples sizes, only looked at admission rates for depression as the
measure of rate of depression. This measure inevitably focussed solely on the more
severe cases of depression and ignored the mild/ moderate cases of depression that,
although still significant, may have been treated on an outpatient basis or indeed not
treated at all.
Although less studied, research has similarly shown that anxiety disorders are
common amongst adults with diabetes and that again they may occur more often in
diabetic patients than in the general population (Jacobson, 1996; Lustman 1988;
Peyrot & Rubin 1997). Symptoms of hypoglycemia associated with poor diabetic
control can be similar to the autonomic symptoms associated with anxiety, for
example, shaking and sweating, and for this reason, patients may find it difficult to
discriminate between hypoglycemia and anxiety and the two conditions may be
confused. Patients may be anxious about their illness and about their ability to adapt
to the treatment and the management regimens that are inherent in the condition. In
addition they have to live with the knowledge that the risk of developing later
complications is directly related to the success with which they are able to integrate
changes into their lifestyle (White 2000).
A comorbid diagnosis of a psychological disorder in diabetes may interfere with
efforts to achieve optimal glycaemic control either via behavioural or physiological
pathways, and therefore is an important factor both in diabetes management and
overall quality of life. The presence of psychological problems can compromise the
individual's ability to engage in optimal self-management, resulting in increasing
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medical complications and perhaps exacerbating psychological difficulties. A
diagnosis of diabetes may influence psychological health, which, in turn, may
influence the patient's ability to address self-management demands (White, 2000).
The psychosocial impact of diabetes was recognised, in one study, as a stronger
predictor of mortality in diabetes patients than a number of frequently used clinical
and physiological outcome variables including HBAlc level, previous hospital
admissions and previous heart attacks (Davis, Hess & Hiss, 1988).
Despite the awareness of an increased prevalence of depression, and perhaps anxiety,
in diabetic populations, recognition and treatment of the disorders has been limited in
clinical practice. Promisingly, successful treatment for depression in diabetic
patients whether pharmacological (Lustman, Griffith, Clouse, Freedland, Eisen &
Rubin, 1997, Lustman, Freedland, Griffith & Clouse, 2000) or psychological
(Lustman, Griffith, Freedland, Kissel & Clouse, 1998) is possible and has been
shown to be associated with improvements in glycaemic control. Interventions that
can help improve self-care and optimise glyceamic control could potentially result in
fewer complications and ultimately an improved quality of life. This evidence
suggests that there is an important association between psychological well-being and
medical outcome.
Better awareness, recognition and treatment of psychological problems are important
in themselves but could also contribute a key element in the outcome of diabetes
management and care. A treatment approach that incorporates an understanding of
the social and psychological as well as the medical ramifications of diabetes should
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be encouraged and where psychological problems exists these should be addressed
and, where appropriate, suitable interventions implemented.
1.6 Psychological Factors in Adjustment to Illness
Illness Representations
The literature provides evidence that the physical and psychosocial functioning of
individuals with chronic medical conditions varies widely and suggests that a number
of mediating variables, including age, gender, illness severity, family functioning,
socio-economic status, parental health, social supports and coping style may
contribute to this variability (Lask, 2000). In addition, the role of psychological
factors in terms of how individuals appraise and made sense of the disease/injury has
been highlighted as an important factor in an individual's adjustment to illness.
The self-regulatory model (Leventhal, Meyer & Nerenz, 1984) seeks to explain this
variation in subjective response to illness and disease. The model focuses on how an
individual represents and responds to the threat carried by illness. In their original
work, Leventhal and colleagues carried out interviews with both chronically ill and
healthy individuals. These interviews gave the researchers an insight into what they
called the "common sense beliefs" individuals held about their illness (Leventhal et
al, 1984). They proposed that these underlying "common sense" beliefs consisted of
several different dimensions and provided patients with a framework in which they
were able to understand and cope with their illness. Leventhal and colleagues
originally defined these beliefs along five dimensions as outlined below:
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• Identity. Referring to the label (i.e. diagnosis) given to the illness and the
symptoms.
• Cause: The perceived cause of the illness, i.e. biological, genetic,
psychosocial.
• TimeLine\The patient's beliefs about the likely time course of the illness, i.e.
is it acute or chronic.
• Consequences:The perceived impact of the illness for the patients eg. in
physical or emotional terms.
• Curability/controllability. The patient's beliefs about how well the illness can
be managed or cured.
Work by other researchers using a variety of different patient groups and
methodologies, has consistently provided support for these five dimensions outlined
by Leventhal's original work (e.g. Baumann, Cameron, Zimmerman & Leventhal,
1989; Bishop, 1987; Lau, Bernard & Hartman, 1989).
Leventhal's self regulatory model of illness behaviour
Leventhal incorporated his model of illness cognitions into a model of illness
behaviour in an attempt to explain the relationship between an individual's cognitive
and emotional representations of their illness and their subsequent coping behaviour.
This model is called the 'Self-Regulatory Model of Illness Behaviour'.
The model is based on problem solving principles and expands on social-cognitive
theory of health behaviour. The model suggests that when an individual is faced
with illness, they deal with this in the same way as they would any other problem
they faced, and in dealing with the problem/illness the individual would go through a
number of different stages.
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Stage 1 involves interpretation of the problem. In the case of ill health, interpretation
of the problem requires making sense of the information available in order to develop
an understanding of the health threat. Interpretation is based on information taken
from a number of different sources concerning the nature of the illness. The self-
regulatory model takes account of pre-existing knowledge and understanding of
illness suggesting that cognitive representations of illness do not arise 'de novo'.
Appropriately, the model takes account of social and environmental factors, placing
the individual in context and acknowledging the crucial roles that these factors play
in the interpretation of signs and symptoms of illness (Bennett, 2003). Information
available includes the signs and symptoms of the illness, information the individual
has gleaned from doctors, friends and others in the social sphere as well as the
individual's prior knowledge and experience of illness. The model proposes that an
amalgamation of this information is cognitively represented along the dimensions
outlined above.
Leventhal's model incorporates a parallel processing response giving equal salience
to both the individual's emotional and cognitive response to a health threat. The
model takes account of the interplay between the cognitive and emotional responses
to illness, acknowledging that the emotional impact of illness on the individual may
contribute to their cognitive interpretation of symptoms (Easterling & Leventhal,
1989).
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Stage 2 of the self-regulatory model involves the individual adopting coping
strategies to deal with the problem in order to regain a state of normality. Adaptive
coping must address both the cognitive and emotional responses to the threat to
health. Once coping strategies have been adopted, the third and final stage of the
model involves appraisal of the strategies used; how successful or unsuccessful have
they been in achieving the desired state? The recursive nature of this model suggests
that the three different stages will continually interact until the coping strategies are
appraised as successful and the desired stage of equilibrium has been regained. An
assumption of the Self-Regulatory model is that when a problem or change to the
status quo is encountered, the individual will be motivated to solve the problem and
return to the state ofnormality. This model is illustrated in Figure 1.2.
Unlike other models adopted in health psychology that provide models of health-
behaviour decision making, for example, the Health Belief Model, the Self
Regulatory Model focuses uniquely on how individuals represent and respond to the
threat of disease.
Evidence in support of the role of illness representations
A number of studies have investigated the predictive power of the Self-Regulatory
Model and the role of illness representations in adaptive outcome. The model
suggests that illness representations may predict mood, behavioural responses to
illness and, where behaviour will influence the disease process, the model may
predict disease outcome (Bennett, 2000). One of the original assumptions of self-
regulation theory was that coping acted as a mediator between illness representations
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and outcome, however there has been limited support for this mediating role in the
literature (Heijmans, 1998; Kemp, Morley & Anderson, 1999; Rutter & Rutter, 2002;
Scharloo, Kaptein, Weinman, Hazes, Willems & Bergen, 1998). Nevertheless,
researchers have suggested that illness representations are associated with outcome
relatively independently of coping and have highlighted the importance of illness
representations in exerting a direct influence on adaptive outcome.
Researchers have examined the roles of illness representations in adaptive and
psychosocial outcome in individuals with chronic disease. Studies have looked at the
role of illness representations in a variety of different illnesses including Irritable
Bowel Syndrome (Rutter & Rutter, 2002), Epilepsy (Kemp et al, 1999), Multiple
Sclerosis (Jopson & Moss-Morris, 2003; Schiaffmo et al, 1998), Chronic Fatigue
Syndrome (Heijmans, 1998; Moss-Morris, 1997) Rheumatoid Arthritis (Scharloo et
al, 1998; Schiaffino et al, 1998) and Chronic Obstructive Pulmonary Disease
(Scharloo et al, 1998). Results have confirmed the contribution of illness
representations to variance in adaptive outcome over and above the influence of
illness severity.
Illness representation dimensions relating to identity, control and consequences
appear to be of particular importance, with a stronger illness identity, belief in
serious consequences and perceived low levels of personal control being predictive
of worse outcome. In patients with chronic fatigue syndrome and multiple sclerosis,
those who believed their illness to be serious, that they had little or no control over it
and saw little possibility of a cure, reported greater mental health problems and less
vitality than those with the opposite set of beliefs (Heijman, 1998, Schiaffino et al,
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1998). A review of literature examining illness perceptions in patients with chronic
illness suggests that perceived consequences and control are important factors
influencing medical and psychological outcome (Heijmans, 1998; Jopson & Moss-
Morris, 2003; Rutter & Rutter, 2002; Scharloo et al, 1998). Studies assessing the
control dimension, possibly the most studied illness representation dimension, show
that perceived internal control is positively related to various indices of medical,
psychological and behavioural well-being (Scharloo & Kaptein, 1997).
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Illness representations and diabetes
A number of studies have used the Self-Regulatory Model to investigate behaviours
and outcome in patients with diabetes. Studies carried out by Hampson and
colleagues in the 1990's appear to be the first published studies, in the field of
diabetes, that have assessed the five components of illness representations, explicitly
using the Leventhal framework. They compared cognitive representations to various
aspects of self-management (Hampson, Glasgow & Toobert, 1990; Hampson,
Glasgow & Foster, 1995). These studies were prospective and controlled for
demographic and medical history variables in order to strengthen the conclusions that
could be drawn about the role of illness representations as determinants, rather than
correlates, of self-management (Hampson 1997). The first of these studies
investigated a sample of women with non insulin dependent diabetes (NIDDM)
(Hampson et al, 1990). Illness representations, in their study referred to as 'personal
models', were assessed using a comprehensive interview including both open-ended
and fixed response questions. Results of this study suggested that personal models
contributed significantly to the prediction of one aspect of self-management, diet, but
were not predictive of self-monitoring behaviours, medication taking or blood
glucose control. Of the personal model constructs, treatment effectiveness was the
most important predictor of dietary self-management.
A further study was carried out several years later to extend this initial study by
including both male and female participants (Hampson et al, 1995). Again, the
sample population had a diagnosis of non insulin dependent diabetes and a similar
methodology was employed. In this later study, the interview was slightly adapted in
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order to improve the internal consistency of the personal model constructs. Again,
results suggested that personal model constructs, especially treatment effectiveness,
were significant predictors of diet, both concurrently and prospectively, and beliefs
regarding cause and treatment effectiveness significantly predicted blood glucose
levels.
The authors concluded that the illness representations framework could be extended
to work in diabetes both as a way of describing individual differences in diabetes
beliefs and as a way of contributing to the understanding of diabetes self-
management. However, there were limitations to these studies. The authors
described their studies as including all five dimensions of the illness representations
outlined by Leventhal, however, in practice the studies used only 3 personal model
constructs namely, cause, seriousness and treatment effectiveness. In their work, the
time-line and consequences representations were collapsed into one single construct
called 'seriousness' and the causal representation consisted of just three items which
assessed only the extent to which the patient blamed him/herself for the onset of
his/her diabetes.
The Hampson et al studies although beginning to explicitly use the Leventhal
framework to assess illness representations used only self management and medical
markers as outcome variables, they did not take account of psychological adaptation.
Subsequently, Watkins and colleagues, again examined the relationship between
cognitive representations of diabetes and diabetes-specific health behaviours, but in
addition their study looked at quality of life variables as an outcome measure
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(Watkins, Connell, Fitzgerald, Klem, Hickey & Ingersoll-Dayton, 2000). The study
involved a large number of adult participants (n=296) and included both non insulin
dependent and insulin dependent diagnoses. The results of this study lent additional
support to the importance of illness representations as predictors of health behaviours
but also to predictors of quality of life. Specifically, the results highlighted that the
patient's understanding of their diabetes as well as their perceived levels of control
over their diabetes were significant predictors of engagement with diabetes specific
health behaviours and positive perceptions of quality of life. However, interestingly
the findings suggested that adherence to treatment regimens did not necessarily
improve quality of life. The authors hypothesised that perhaps good adherence to
treatment management may negatively impact on quality of life due to an increased
perceived burden.
Although the study does lend support to the importance of illness representations not
only as predictors of health behaviours but also as predictors of quality of life, the
study was conducted as a secondary analysis of data and it did not use a validated or
reliable measure of illness representations. Similarly, the illness representation
constructs they used were slightly different from definitions used elsewhere; causal
beliefs were related to changes in blood glucose level as opposed to the initial onset
of the diabetes and consequences assessed beliefs regarding the likelihood ofmedical
complication as opposed to social and financial consequences as addressed elsewhere
in the literature. Unlike the Hampson et al studies the authors did not assess for
duration of diabetes nor illness severity and therefore these factors were not
controlled for in the results.
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In 1996, Weinman and colleagues developed a questionnaire for assessing illness
representations (Weinman, Petrie, Moss-Morris & Home, 1996). Although
Leventhal argued that interviews were the preferred method to examine beliefs as
they allowed cognitions to be subject generated rather than researcher generated, this
questionnaire enabled researchers to access a greater number of participants.
Completion of a questionnaire is far less time-consuming than an interview. The
measure, called The Illness Perception Questionnaire, included all five of
Leventhal's original constructs and provided a well validated and reliable measure by
which to investigate illness representations. A comprehensive review of studies
using the measure, highlighted some problems with internal consistency and
therefore the questionnaire was revised several years later to improve the reliability
of the measure and to include an emotional representation construct which although
integral to the self-regulatory model, had been left out of the original version (Moss-
Morris, Weinman, Petrie, Home, Cameron & Buick, 2002).
A study carried out by Law et al in 2002 was the first to use this revised measure in a
population with diabetes (Law, Kelly, Huey & Summerbell, 2002). The study
examined the relationship between illness beliefs, diabetes self-management
behaviours and psychological well-being in a population of adolescents with insulin
dependent diabetes. Analyses concluded that the adolescent participants perceived
their diabetes to be of chronic duration and they believed that they had high levels of
personal control over their illness. They perceived moderate levels of treatment
control and moderate consequences of diabetes on their lives. There were no gender
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differences in the illness representations held and neither age nor illness duration was
significantly associated with any aspect of illness beliefs (Law et al, 2002). Unlike
other studies (Hampson et al, 1990, 1995, Watkins et al 2000) illness beliefs did not
significantly account for variance in any of the self management behaviours
however, illness beliefs were found to be important predictors of psychological well-
being. Perceived consequences of diabetes was a significant positive predictor of
anxiety and the personal control construct was a significant predictor of positive
well-being.
The generalisability of this study is limited by the small sample size, and the use of a
standardised adult questionnaire, the Well-Being Questionnaire, to assess
psychological well-being in adolescents. However, it does again support the
association between illness representations and psychological well-being in
individuals with diabetes and suggests that cognitive variables may prove valuable
targets for intervention.
Both the Watkins et al (2000) and the Law et al (2002) studies used a cross-sectional
methodology, therefore relationships between variables cannot be understood as
causational and this method does not capture the dynamic interplay of the self-
regulatory model. A longitudinal study would be a more satisfactory method of
investigating the relationship between illness representations and outcome variables.
A study by Skinner and colleagues looked at illness representations, and social
support as predictors of self care behaviours and well-being (Skinner, John &
Hampson, 2000). Fifty-two adolescent participants with insulin dependent diabetes
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completed assessment measures at baseline and at six month follow up. Results
found that overall girls experienced higher levels of anxiety and depression
symptoms than boys but neither age, duration of illness nor socio-economic status
was associated with psychological well-being. The perceived impact of diabetes was
a significant positive predictor of anxiety and depression and a significant negative
predictor of psychological well-being. Changes in perceived levels of social support
from baseline to follow up were similarly predictive of psychological well-being.
Personal model constructs assessing perceived seriousness and control were
significant predictors of dietary self-management.
The most recently published study to lend support to the role played by illness
representations in the psychological well-being of individuals with diabetes suggests
that the perceived impact of and identity with the illness is significantly associated
with depression and anxiety symptoms and is negatively associated with positive
aspects of psychological well-being. Beliefs in treatment effectiveness in this study
were also significantly associated with positive psychological well-being (Edgar &
Skinner, 2003). Again, this study investigated the role of illness representations in
adolescents with insulin dependent diabetes. The role of coping as a mediating
variable between illness representations and psychological well-being was
investigated, however, no robust evidence was found to support this mediating role
bringing into question Leventhal's original model that illness representations
determine coping strategies. These results suggest that illness representations are
more predictive of psychological outcomes than coping strategies.
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1.7 The social context of illness representations
Just as the social network of a chronically ill patient may be affected by the illness,
so the response of the social network may influence a patient's health related beliefs
and behaviours (Croyle & Hunt, 1991). The process of developing illness
representations does not take place within a vacuum, but rather is an inter-personal as
well as intra-personal process. LeventhaTs model is particularly useful in this
context as it acknowledges the role of social factors in the appraisal of illness and
explicitly states that information from significant others may be especially important
during the appraisal stage (Leventhal et al, 1984). Beliefs held by people within a
patient's social network, expressed in the form of advice or opinions, can affect the
patient's illness representations and health related behaviours.
The self-regulatory framework needs to be extended into the social context (Law,
2002; Leventhal et al, 1997), however, to date there has been relatively little research
done to integrate illness beliefs and representations into the interpersonal context.
The role of family members in shaping particular illness beliefs has been investigated
by a small number of researchers who have investigated the extent to which patients'
and spouses' beliefs about illness differ and to what extent this impacts on the
patient's psychological well-being and adaptation to illness (Heijamns, de Ridder &
Bensing, 1999; Law, 2002, Richards, Fortune, Chong, Mason, Sweeney, Main &
Griffiths, 2004; Salewski, 2003).
Diverging views on an illness can constitute a great source of stress (Leventhal et al
1985). Heijmans et al (1999) carried out a cross-sectional study comparing the
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illness representations held by patients suffering from Chronic Fatigue Syndrome or
Addison's Disease with those held by their spouses. The findings provided evidence
that where there was dissimilarity in a couple's illness representations this had an
impact on the patient's coping and adaptive outcome. Richards et al (2004)
investigated dissimilarity in illness representations held by patients with a chronic
medical condition and their partners and included a measure of psychological distress
for both the patient and their partner. Their findings provided evidence that
divergence in patients' and partners' beliefs were significantly associated with levels
of psychological distress in both patients and their partners.
Law (2002) investigated dissimilarity in adolescent and maternal representations of
Type 1 diabetes. Fie found that adolescents' and their mothers' beliefs about illness
converged on all but two of the illness representation dimensions. Mothers perceived
that their adolescent's diabetes had significantly more serious consequences and had
a significantly greater emotional impact on their child than the adolescents
themselves did. This study did not find any association between dissimilarity across
illness representations and adolescent psychological well-being, however it did
suggest that the high degree of consistency in the beliefs of adolescents and their
mothers may be ofbenefit to their psychological well-being.
A similar study compared illness representations held by patients and their health
care providers (Heijmans, Foets, Rijken, Schreurs, de Ridder & Bensing, 2001). The
importance of the relationship between patients and their health care providers has
been recognised as important in the management of chronic disease, but prior to this
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study there had been little attempt to systematically compare patients' and providers'
perceptions of the consequences of a chronic disease. As Leventhal has commented,
many aspects of our common sense representations of illnesses emerge from our
interpretations of the information to which we are exposed during medical
encounters (Leventhal et al, 1997).
Heijmans and colleagues studied a sample of 580 patients and their GPs and asked
them to complete questionnaires about the stressors associated with the patient's
illness (Heijmans et al, 2001). Their findings provided evidence that patients and
doctors often diverge in the way they think about illness. In their sample of patients
with osteoarthritis, doctors judged the disease as more serious than the patients
themselves. The results suggested that the perceptions of illness held by GPs were
more congruent with medical knowledge than with the experiences of patients.
Heijmans et al (2001) propose that differences between the perceptions of patients
and health-care providers about the stressors confronting patients with chronic
disease may lead to misunderstandings and disrupt effective communication. In
addition they found that incongruence in patients' and GP beliefs were greater where
treatment was less clear and that incongruence between patient and GP was
association with worse health status of the patient.
In view of this and in light of the fact that there is currently no clear treatment
protocol in the management of CFRD, one question addressed by the current study
was to what extent differences in illness representations of diabetes existed between
the cystic fibrosis patients and the staff involved in their care. The CF population
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generally have long-standing and, at times, intensive contact with their medical team
and therefore understanding and effective communication between parties is of
utmost importance in the provision of good quality care.
As the incidence of diabetes increases in the CF population, a greater understanding
of the beliefs held by patients about this condition together with a greater insight into
staff perceptions of this illness should lead to ways to foster better communication
and adjustment in this client group. The current study will focus specifically on
beliefs regarding consequences and control of diabetes in comparing the illness
representations held by patients and staff.
1.8 Summary
A greater understanding of patients' beliefs about their illness should lead to ways to
foster better adjustment (Law, 2002). The mediating role of coping strategies within
the Self-Regulatory Model is questionable, nevertheless, previous research has
highlighted the direct role of illness representations in predicting psychological
adjustment. To date, research interested in the association between illness
representations and psychological well-being has been conducted with adolescents
and adults with both Type 1 and Type 2 diabetes.
Since the development of the revised Illness Perceptions Questionnaire (Moss-Morris
et al, 2002), diabetes research using the measure has focussed on adolescent
adjustment to diabetes and the measure has not yet been used with an adult sample.
In addition, there appears to be no research investigating illness representations and
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psychological adjustment to diabetes in patients with a pre-existing chronic illness,
as is the case for patients with diabetes diagnosed as a secondary chronic
complication to cystic fibrosis.
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1.9 Aims
The aims of the current study were to investigate the relationship between illness
representations, as defined by the Self-Regulatory Model, and psychological
adjustment in patients with insulin dependent diabetes. The study aimed to compare
the relative representations of illness held by patients with Type 1 diabetes with those
held by patients with cystic fibrosis related diabetes and to determine whether
differences in perceptions of consequences and control existed. As patients with
cystic fibrosis have had experience of adapting to an existing complex and time-
consuming daily treatment regimen it was hypothesised that the demands placed on
these patients, by the additional stressor of diabetes, would have less impact than the
similar demands placed on patients diagnosed with diabetes with no previous
experience of chronic illness or self-management.
The study also aimed to determine whether, as had been shown in previous research,
illness representations of diabetes were predictive of subjective measures of anxiety
and depression.
Finally, the study aimed to move the Self-Regulatory framework in to the social
context by assessing the illness representations of diabetes held by staffworking with
the cystic fibrosis population. Little is known about how illness representations form
or how social interactions affect patient's ideas and beliefs, however there is
speculation that where there is a mismatch and individuals do not share a common
illness model, that adherence and psychological well-being is affected. This view
has been supported in previous studies exploring patient's and spouse's beliefs
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(Heijamns et al, 1999) and patient's and general practitioner's beliefs (Heijmans et
al, 2001). Anecdotally, medical staff involved in the care of patients with cystic
fibrosis related diabetes assume that the additional diagnosis will bare little
additional impact on the patient. The current study aimed to investigate staff
representations of the consequences and control of diabetes in their patients and to




Cystic Fibrosis patients will perceive fewer consequences and more control of their
diabetes than Type 1 Diabetic patients.
Hypothesis 2
Low perceived control and high perceived consequences will be associated with
higher levels of anxiety and depression in both groups.
Hypothesis 3
Differences will exist between staff and patients' illness representations on





A between-subjects design was used.
Calculation of Power and Effect Size
In order to ensure power at 0.8, to detect a large effect size with a = 0.05, the
necessary sample size required for two equal groups would be 26 participants in each
sample group (Cohen, 1992). However, as there was a finite population of 31
eligible patients with a comorbid diagnosis of cystic fibrosis and insulin dependent
diabetes attending the clinics, power of the study was ensured by increasing the
number of participants in the Type 1 diabetic sample.
Participants
The samples were recruited from the outpatient lists of three adult clinics in two
large general hospitals in Edinburgh and Tayside. Eligibility criteria were
individuals aged between 16 and 56 with a diagnosis of insulin dependent diabetes.
Participants were drawn from two samples: (1) patients whose diabetes was
secondary to cystic fibrosis (cystic fibrosis related diabetes) and (2) patients of a
similar age, sex and duration of diabetes with a diagnosis of Type 1 diabetes. The
upper age limit corresponded to the eldest individual in the cystic fibrosis sample,
any older individuals in the Type 1 diabetes sample would be impossible to match.
Patients were excluded if they had any other serious co-morbid medical condition or
multiple diabetic complications.
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A total of thirty-one potential participants with a diagnosis of cystic fibrosis related
diabetes were approached of whom twenty-two agreed to participate, a response rate
of 71 percent. One hundred and fifteen Type 1 diabetic patients were approached of
whom 54 responded, a response rate of 47 percent. Two respondents from the Type
1 diabetic sample did not complete the questionnaires appropriately and seven
respondents were excluded from the study due to the presence of multiple diabetic
complications in six of the respondents and due to the presence of co-morbid
psychiatric disease in one case. The final sample consisted of 22 participants with
cystic fibrosis related diabetes and 45 participants with a diagnosis of Type 1
diabetes. The staff group working with the cystic fibrosis patients were also invited
to take part in the study (n=25), 17 agreed to participate.
2.2 Procedure
Ethical Considerations
Ethical principles are concerned with protecting the rights, dignity and welfare of
research participants. The major ethical principles in clinical psychology research
are informed consent, avoidance of harm, privacy and confidentiality (The British
Psychological Society, 2000; Barker, Pistrang & Elliot, 2002). The current study did
not involve any element of deception, withholding of information or covert
observation. All participants were provided with full information about the study
including reasons for the research and what participation would involve before
agreeing to take part. Participants were provided with an information sheet that
outlined what the study was about, the study procedure, any potential risks or
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benefits and a statement informing the individual that he/she was free to withdraw
from the study at any time (Appendix A).
In addition, although the researcher was part of the cystic fibrosis team she did not
have any direct therapeutic input with any of the participants with cystic fibrosis.
The researcher was not involved in any way with the management or treatment of the
participants with Type 1 diabetes. This allowed for free and informed consent of all
participants.
All information provided was treated as confidential with only a number used to
identify the participant. It was considered unlikely that the participants would suffer
any harm as a result of participating in this study, however, participants were advised
that should they encounter any problems, they should contact the researcher.
Ethical approval for the current study was obtained from the Lothian research ethics
medical/oncology committee and the Tayside Committee on Medical Research
Ethics.
Pilot Study
Ten eligible participants were sent an invitation letter and patient information sheet
prior to clinic attendance. This explained the purpose of the research and made the
participants aware of the likely presence of the researcher at their next clinic
appointment. On arrival at the outpatient clinic, potential participants were
approached by the researcher who reiterated the purpose of the study, explained
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again what would be involved and asked each individual if they would be willing to
take part. Those individuals who agreed to participate completed consent forms.
Demographic details were gathered for all participants. These consisted of the
patient's age, sex, employment status, marital status, duration since diabetes
diagnosis, and prescribed frequency of insulin injections.
The participants were given the option of completing the questionnaires in a quiet
room beside the clinic or in the waiting area. This option was given in order that
participants would not be reluctant to take part simply due to having to spend extra
time at clinic. The researcher explained the instructions to each participant
individually and remained on hand to answer any questions that might arise.
Questionnaires took between 10 and 20 minutes to complete.
The pilot study highlighted a significant potential problem in that non-attendance at
clinic appointments was not uncommon, particularly for the Type 1 diabetic group.
In addition, Type 1 diabetic patients were only invited to the outpatient clinic every
four to six months. Relying on eligible participants to attend their appointment
would therefore have significantly limited recruitment. Consequently an amendment




This amendment involved accessing the hospital database to obtain home address
details for all the eligible participants. In addition to the invitation letter and patient
information sheet, each potential participant was also sent a personal information
sheet, in order to gather demographic details, a consent form and the study
questionnaire pack. Participants were asked to read the information and, if happy to
participate, to complete the personal information, study questionnaires and consent
form and return them to the researcher in the stamped addressed envelope provided.
Nurses working on the respiratory ward and therefore in contact with cystic fibrosis
patients (n =15) as well as members of the adult cystic fibrosis team (n = 10) were
asked to complete a short adapted version of the Illness Perceptions Questionnaire -
Revised (see Appendix B). Members of the cystic fibrosis team were approached
directly by the researcher and asked if they would agree to take part. Ward staff
were approached by the charge nurse. A total of 8 members of the cystic fibrosis
team and 9 ward staff agreed to participate and returned completed questionnaires.
2.3 Measures
Copies of all measures used are included in Appendix B.
Self-report questionnaires were presented in the same order to each individual
participant. They are described in presenting order below:
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The Weil-Being Questionnaire (Bradley, 1994). This 22 item measure was
developed specifically for use with diabetic patients. Each item is scored on a 0 to 3
Likert scale. It is designed to be particularly sensitive to the more cognitive
symptoms of anxiety and depression and to minimise as far as possible the inclusion
of somatic symptoms that may also be common in poorly controlled insulin-
dependent diabetes. The measure consists of four sub-scales measuring anxiety,
depression, positive well-being and energy. Reliability ratings suggest Cronbach
alpha coefficients of 0.74, 0.67, 0.8 and 0.64 for each subscale respectively. It offers
an advantage over the Hospital Anxiety and Depression Scale in that it provides a
measure of positive mood state. The scale is increasingly being used for the purpose
of auditing psychological outcomes in diabetes care and has been widely used in
research examining illness representations and psychological well-being in patients
with diabetes (Bradley 1994; Law, 2002; Law, Kelly, Huey & Summerbell, 2002).
The author suggests that the scale may be useful to compare samples of people with
diabetes with other patient groups (Bradley, 1994).
The Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983). This
measure consists of 14 items divided into two subscales measuring depression and
anxiety symptoms. The HADS specifically avoids items that measure physical
manifestations of depression, as such items may lead to inappropriately elevated
scores in populations of patients suffering from a medical condition. The scale was
originally developed for use in general medical out-patient clinics but is now widely
used in clinical practice and research. The subscales demonstrate good internal
reliability with reported Cronbach's alpha scores ranging from .77 to .86 (Crawford,
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Henry, Crombie & Taylor, 2001). The scale is short and easy to use and has good
face validity.
The Illness Perceptions Questionnaire - Revised (Moss-Morris et al)
This measure was used to measure participants' illness representations. The original
Illness Perceptions Questionnaire (Weinman, Petrie, Moss-Morris & Home, 1996)
was developed to provide a quantitative assessment of the five illness representation
components, namely identity, consequences, timeline, control/cure and cause in
Leventhal's Self Regulatory Model. However, a critical review of published studies
using the measure revealed some variation in the internal consistency of specific
subscales. The scale was subsequently revised to strengthen the psychometric
properties of the original scale and to improve the reliability of the subscales. The
revised questionnaire measures participants' illness beliefs along 9 dimensions. The
control subscale was divided into two parts; personal control, the degree to which
individuals believe that they can control/manage their symptoms, and treatment
control, beliefs in the efficacy of treatment to control/manage their symptoms. Also,
an additional timeline scale was developed to look at cyclical beliefs regarding
illness variability and unpredictability, as well as acute/chronic timeline beliefs. Two
further subscales were also included in the revised version taking account of
emotional representations, an important component of the Self-Regulatory model
that was overlooked in the original IPQ scale, and "illness coherence", to assess to
what extent patients believe that they have a coherent understanding of their illness.
All of the new subscales demonstrate good internal reliability with Cronbach alphas
ranging from 0.75 to 0.89 (Moss-Morris et al, 2002).
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The measure is divided into three sections. The identity scale is presented first and
consists of commonly experienced symptoms. Patients are asked whether or not they
have experienced the symptom since their illness and whether or not they believe the
symptom to be specifically related to their illness. The next section specifically
addresses identity, consequences, timeline, coherence and emotional beliefs. These
are rated on a 5 point Likert type scale from strongly disagree to strongly agree.
Finally, the causal dimension is presented in a separate section using the same Likert
type scale. Overall the measure consists of 70 items.
Illness Perceptions Questionnaire - Revised: Adapted StaffMeasure
One of the aims of the study was to determine whether staff beliefs about a diagnosis
of diabetes were similar to those of the cystic fibrosis patients themselves.
Specifically, the study aimed to determine whether beliefs about consequences and
control of diabetes were similar between the staff and patient groups. To investigate
this question an adapted version of the IPQ-R was developed for staff. Only the
items concerned with consequences and control were presented to the staff sample.
Wording on the staff questionnaire was based on advice from the original authors
replacing "My diabetes" with " My patients' diabetes" (Moss-Morris, personal




Glyosylated haemoglobin (HbAlc). This reliable index of blood glucose control
reflects average glycaemic control over the preceding 3 months (Marshall & Barth,
2000). This measure was used as an index of diabetes illness severity. The HbAlc
level was monitored routinely at the clinic appointment as part of diabetes care and
not especially for this study. The HbAlc level recorded most recently to the date
that the patient completed the study questionnaires was used.
Forced Expiratory volume in 1 second (FEV1). FEV1 levels were used as a measure
of illness severity in patients with cystic fibrosis. FEV1 measures the amount of air
the individual can blow out of their lungs in one second, providing information about
the state of the lungs. This measure is routinely taken at clinic as a measure of lung
function. The health of the individuals' lungs is assessed according to how closely
their FEV1 compares with that of a healthy individual of the same age and height.
Table 2.1 shows a classification ofCF lung disease severity. The FEV1 level used as
a measure of illness severity in the current study was that recorded nearest to the date
on which the patient competed the study questionnaires.
Table 2.1. Classification of Cystic Fibrosis Disease Severity
Mild FEV1 70%-90% ofexpected result
Moderate FEV1 40%-69% ofexpected result
Severe FEV1 less than 40% ofpredicted result
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2.4 Statistical Data Analysis
Statistical analysis was conducted using SPSS version 11.0 for Windows. All data
were checked for assumptions of normality and homogeneity of variance before
parametric analysis. Data that produced neither significant skewness nor kurtosis
was assumed to follow a normal distribution (Tabachnik & Fidell, 1996).
Where exploratory data analysis revealed departures from normality and the data was
positively skewed, logarithmic transformation was used to modify the data to fit the
underlying assumptions of parametric statistics as recommended by Tabachnik &
Fidell (1996). This was carried out for the following measures:
• The Hospital Anxiety and Depression Scale
• The Well-being Questionnaire Anxiety Scale
• The Illness Perceptions Questionnaire Dimensions:
Timeline cyclical
Emotional Representations
Where data was negatively skewed, reflection and logarithmic transformation was
performed to modify the data. This was carried out for the following measures:
• The Illness Perceptions Questionnaire Dimensions:
Timeline Acute/Chronic Dimension
Personal Control Measure
Following transformation data followed a normal distribution.
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Where data was skewed due to the presence of outliers, ie HbAlc level in the Type 1
group and duration since diagnosis in the CFRD group, these outliers were
examined. Examination of the outliers could find no reasons for the atypical scores,
therefore analysis was carried out both with and without the outlying values. Such
analysis produced equivalent results allowing for confidence in the findings.
Student's t-test and one-way ANOVA analysis were performed to detect difference
between groups. Pearson's Product Moment Correlation analysis was performed to
detect associations between variables where the data was normally distributed.
Spearman's rho correlations were performed on non-parametric data. To test
whether illness representations could predict levels of anxiety and depression,
stepwise multiple regression analysis was performed. For all tests carried out a
significance level of p< 0.01 was set to protect the familywise alpha level and reduce
the chances ofmaking a Type 1 error due to multiple comparisons (Cohen, 1992).
Effect Size
The effect size gives a measure of the magnitude of the result independent of the
sample size. Conventions proposed by Cohen (1988) arbitrarily define three levels
of effect size, for the t-test of the difference between independent means these are
defined as small 0.20, medium 0.50 and large 0.80. For the product moment




3.1 Description of Sample population
Demographics
Gender, employment and marital status information is shown for both groups in
Table 3.1. There were more males than females in the Type 1 diabetic group
(M=60%, F=40%) but there was an equal split within the Cystic Fibrosis related
diabetes (CFRD) group (M=50%, F=50%). The majority of Type 1 diabetic patients
were in full time employment (76%) and this group included no students. In
comparison, only 27% of the CFRD group were in full time employment, 27% were
students and 32% were unemployed. Ability to work in the CFRD sample may be
largely driven by the limitations of the disease, therefore this figure is likely to reflect
the worse overall state of health in the CFRD group.
The majority of the Type 1 group were either married or living with a partner (47%
and 20% respectively) whereas the majority of the CFRD group were living with
parents (41%) with only 14% of this group married and 27% living with a partner.
The mean age for the Type 1 group was 36.8 years and for the CFRD group 24.59
years, means and standard deviations for age are shown in Table 3.2. There was a
significant difference in age between the two groups with the Type 1 group being
significantly older than the CFRD group (t = 5.502, p =<.01). This difference in age
may account for some of the variance shown in marital status.
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Male 27 (60) 11 (50)




Living with Partner 9(20) 6(27)
Living with Parents 4(9) 9(41)
Divorced 1(2) 0(0)
Separated 3(7) 1(4)
Missing data 1 (2) 0(0)
Employment Status
Full Time 34 (76) 6(27)
Part Time 7(16) 3(14)
Student 0(0) 6(27)
Unemployed 3(6) 7(32)
Missing data 1(2) 0(0)
Clinical Characteristics
Duration ofDiabetes and Blood Sugar Level.
Means and standard deviations for duration of diabetes and blood sugar (HbAlc)
levels are given in Table 3.2. Duration of diabetes data was missing for two
participants in the Type 1 group and blood sugar level data was missing for one
participant in the CFRD group. There was no significant difference between groups
for duration since diagnosis (t = 0.319, p = .751). The Type 1 group included one
outlier on the measure of blood sugar level though examination of this outlier could
find no reason for this atypical result. T-tests were conducted with and without the
outlier and both provided evidence that there was no significant difference between
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groups (with outlier: t = 0.033, p = .974; without outlier: t = -0.195, p = .847) for
HbAlc allowing confidence in this result.
Table 3.2. Means and Standard Deviations of Age, Duration since diagnosis (yrs) and
blood sugar (HbAlc) levels by group
duration since blood
diabetes diagnosis age diagnosis sugar level
type 1 diabetes Mean 36.80 4.98 8.11
Std. Deviation 9.23 2.79 1.35
Range 32 9.3 7.5
N 45 43 45
CFRD Mean 24.59 4.73 8.10
Std. Deviation 6.84 3.38 1.97
Range 23 14.7 7.3
N 22 22 21
Total Mean 32.79 4.90 8.11
Std. Deviation 10.25 2.98 1.56
Range 37 14.7 8.5
N 67 65 66
CFRD: Cystic Fibrosis Related Diabetes
Frequency of injections:
Frequency of injections in the CFRD group was fairly evenly spread between 1 and 5
injections a day, whereas the majority of type 1 diabetics injected 4 times a day.
This is displayed graphically in Figures 3.1 and 3.2.
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Figures 3.1 & 3.2. Frequency of injections





The breakdown of the CF group by disease severity is shown in Figure 3.3. The
sample consisted of seven individuals with mild disease (FEV1 percent predicted >
70%), 8 with moderate severity disease (FEV1 percent predicted 40-69% ) and seven
with severe disease (FEV1 percent predicted <40%).





Descriptive/exploratory analysis relevant to each research question will be presented
prior to analysis directly relating to the study hypotheses.
Hypothesis 1
Cystic Fibrosis patients will perceive fewer consequences and more control of
their diabetes than Type 1 diabetic patients.
Descriptive information relating to the illness representations held by the Type 1 and
CFRD groups is presented prior to analysis directly related to the hypothesis. In
addition, associations between age, duration of diabetes, HbAlc levels and illness
representations are explored.
Descriptive analysis: Illness Representations
The means and standard deviations of illness representations for both the Type 1
diabetic group and the cystic fibrosis related diabetic group are shown in Table 3.3.
Examination of the mean scores for the different dimensions of illness
representations shows that individuals diagnosed with Type 1 insulin dependent
diabetes perceive their diabetes to be of chronic duration and they perceive high
levels of personal control over their illness. These Type 1 diabetes patients also
perceive high levels of illness coherence, suggesting that they have a good
understanding of their illness, and scored moderately on perceived levels of
treatment control and consequences of their illness. The Type 1 group were largely
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positive in terms of their emotional response to their diabetes and did not perceive
high levels of variation in their illness over time.
The illness representations held by the CFRD group were broadly similar. They too
perceived their diabetes to be of chronic duration and perceived a good
understanding of their illness. Similarly, they scored moderately on beliefs relating
to levels of treatment control, however the mean score for the CFRD group was
lower than the Type 1 group on perceptions of personal control. The cystic fibrosis
group perceived moderate consequences of their diabetes and were relatively positive
in terms of their emotional perceptions directly related to their diabetes. Again, in
concordance with the Type 1 group, individuals with cystic fibrosis did not perceive
high levels of variation in their illness over time.
Cause:
Twenty-eight percent of Type 1 diabetics gave inheritance as the primary cause for
their diabetes followed by stress/worry (18%), germ/virus (18%) and chance/bad
luck (13%). The majority of the Cystic Fibrosis related diabetes group detailed
having CF as the primary cause of their diabetes (68%) followed by diet (9%),
chance/bad luck (9%) and germ/virus (4.5%). A breakdown of the primary causes
given is shown in Figures 3.4 and 3.5.
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Figure 3.4. Primary cause of diabetes given by Cystic Fibrosis group
Diagnosis: CFRD
Causes




stress/worry germ/virus chance/bad luck overwork no causes given
hereditary diet family probs don't know
Causes
Associations between age, clinical measures and Illness Representations:
There were no significant correlations between age, the clinical measures of duration
of diabetes or HbAlc level, and any of the illness representation dimensions for
either the Type 1 diabetic group or the CFRD group. Correlations were run with
and without the outlier in the Type 1 diabetic group for the HbAlc measure and
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again with and without the outlier in the CFRD group for duration since diagnosis.
Results for each analysis were the same giving confidence in the findings reported.
Correlations between IPQ consequences, treatment control, personal control and CF
disease severity:
Spearman's correlation analysis was carried out for the three different CF severity
groups and the IPQ illness representation dimensions of consequences, treatment
control and personal control. There were no significant correlations between CF
disease severity and perceived consequences, treatment control or personal control.
Correlations as given in Table 3.4.
Hypothesis 1 related analysis
The hypothesis that cystic fibrosis patients would perceive fewer consequences and
more control of their diabetes than Type 1 diabetic patients was investigated by
assessing the diabetes specific illness representations held by both groups using the
diabetes specific version of the Illness Perceptions Questionnaire - Revised (IPQ-R)
(Moss-Morris et al, 2002). One-way ANOVA analysis was performed to compare
differences in scores between the Type 1 diabetics and the CFRD patients on the
dimensions of perceived consequences, personal control and treatment control. See
Table 3.3 for a breakdown ofmeans and standard deviations. Alpha level was set at
p< .01 to preserve the familywise alpha level (Cohen, 1992).
No significant differences between groups were found on the IPQ dimensions of
perceived consequences or treatment control. (Table 3.5). Analysis of the observed
power of these tests shows that power was calculated at .366 for consequences and
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.124 for treatment control. Despite non-significant results, a calculation of effect size
(d) indicated that there was a medium effect of group on perceived consequences (d
= .43) with Type 1 diabetic patients perceiving more consequences and a small effect
of group on perceived treatment control (d = .21) (Lipsey, 1990) with the Type 1
group perceiving higher levels of treatment control.
A significant effect of group was found on the dimension of perceived personal
control. Individuals with a diagnosis ofType 1 diabetes rated their perceived
personal control to be significantly higher than individuals diagnosed with insulin
dependent diabetes secondary to cystic fibrosis (F(l,65) = 11.576, p = .001). The
estimate of effect size d indicated a large effect size (d = .93).
Table 3.5. One-way ANOVA: Differences between the Type 1 group and the CFRD
group on the IPQ dimensions; consequences, treatment control and personal control
Mean (sd) F(l, 65) Sig.
Type 1 CFRD
IPQ consequences 3.09 (.58) 2.83 (.67) 2.693 .106
IPQ treatment control 3.56 (.54) 3.45 (.50) .646 .424
IPQ personal control 4.42 (.53) 3.92 (.57) 11.576 .001
Conclusions:
• The research hypothesis that cystic fibrosis patients would perceive fewer
consequences and more control of their diabetes than the Type 1 group was
not supported as no significant differences between groups were found on
perceived levels of consequences or treatment control.
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• Contrary to the hypothesis, results showed that cystic fibrosis related diabetes
patients perceived significantly lower levels of personal control over their
diabetes than individuals with Type 1 diabetes.
• There were no significant differences between CF patients with differing
disease severity on dimensions of perceived consequences, treatment control
or personal control of their diabetes.
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Hypothesis 2
Low perceived control and high perceived consequences will be associated with
higher levels of anxiety and depression in both groups.
Initial exploratory analysis was carried out to assess for levels of psychological well-
being in both the Type 1 and CFRD groups and to look for any differences between
groups on these measures. Associations between subscale scores on the different
psychological well-being measures and between age, duration of diabetes, HbAlc
levels and psychological well-being were explored. Exploratory analysis is
presented prior to analysis related directly to the hypothesis.
Exploratory Analysis: Psychological Weil-Being
Means and standard deviations of the psychological well-being scores for both the
Type 1 and CFRD patient groups are presented in tables 3.6 and 3.7.
Table 3.6. Means and standard deviations for scores on the HADS
diabetes diagnosis HADS total anx HADS total dep HADS total
type 1 diabetes Mean 6.33 2.80 9.13
Std. Deviation 4.09 2.62 5.90
N 45 45 45
CFRD Mean 4.73 2.32 7.05
Std. Deviation 2.95 2.59 4.89
N 22 22 22
Total Mean 5.81 2.64 8.45
Std. Deviation 3.81 2.60 5.64
N 67 67 67
73
Table 3.7. Means and standard deviations for scores on the WBQ
WBQ
WBQ anxiety depression WBQ energy WBQ
diabetes diagnosis score score score well-being
type 1 diabetes Mean 4.76 4.24 7.38 12.67
Std. Deviation 3.45 2.92 2.55 3.55
N 45 45 45 45
CFRD Mean 3.18 3.36 6.95 13.95
Std. Deviation 2.48 2.15 1.94 3.09
N 22 22 22 22
Total Mean 4.24 3.96 7.24 13.09
Std. Deviation 3.23 2.71 2.36 3.44
N 67 67 67 67
WBQ: Well-Being Questionnaire; CFRD: Cystic Fibrosis Related Diabetes
Hospital Anxiety and Depression Scale:
Mean scores were within the normal range on the Hospital Anxiety and Depression
Scale (HADS). However, 31% of Type 1 patients and 14% of the CFRD sample
reported a HADS anxiety score greater than 8 suggesting that they experienced levels
of anxiety that were at least borderline for clinical significance. Similarly 7% of
Type 1 and 9% of the cystic fibrosis sample scored above the cut off of 8 on the
HADS depression scale again suggesting clinically significant levels of depression.
For all but one patient (Type 1), a score above the clinical cut off on the depression
measure, indicated a score above the clinical cut off on the anxiety measure.
Two-tailed t-tests showed that there were no significant differences between the
individuals with Type 1 diabetes and those with cystic fibrosis related diabetes
(CFRD) on either of the subscales measures of the HADS or on the HADS total
score. See table 3.8.
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The Well-being Questionnaire:
No clinical cut offs are published for the WBQ. One-sample t-tests found that mean
scores for depression and positive well being did not differ significantly from normal
adult Type 1 diabetic samples (data taken from Bradley, 1994) for either the study
Type 1 or CFRD groups. There was a significant difference on the anxiety measure
for the Type 1 group (t=2.045, p < .001) but not the CFRD group indicating that the
Type 1 study sample reported significantly higher levels of anxiety symptoms than a
normative comparison group.
Psychological well-being as measured by the WBQ again showed no statistically
significant differences between groups on the measure of depression or on the
measures of positive well-being (ie. energy and positive well-being). However,
individuals with Type 1 diabetes reported significantly more anxiety symptoms than
individuals with CFRD (t = 2.491, p = .015). These results are given in Table 3.9.
Table 3.8. Independent Samples t-test: Differences between Type 1 and CFRD groups
on the HADS measure




HADS depression 1.642 65 .105 -.35 3.56
HADS anxiety .466 55 .643 -.34 .55
HADS total 1.121 63 .266 -.16 .57
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Table 3.9. Independent Samples t-test: Differences between Type 1 and CFRD groups
on the WBQ measure




WBQ anxiety 2.491 62 .015 .094 .85
WBQ depression 1.255 65 .214 -.52 2.28
WBQ energy .686 65 .495 -.81 1.65
WBQ well-being -1.453 65 .151 -3.06 .48
Associations between clinical measures, age andpsychological outcome
Neither duration of diabetes nor blood sugar level was significantly correlated with
any psychological well-being measure for either the Type 1 or the CFRD groups.
Age was positively correlated with the HADS depression score in the Type 1 group
(r=0.402, p= .01), but not with other FIADS or WBQ measures and there were no
significant correlations between age and any of the psychological outcome measures
for the cystic fibrosis related diabetes group.
Association between psychological measures and CF disease severity
Spearman's correlations were carried out to investigate whether there was any
association between scores on the psychological well-being measures and level of
Cystic Fibrosis disease severity in the CFRD group. The CF group was split into
mild (n=7) moderate (n=8) and severe (n=7) disease severity categories.
Correlations were performed for the subscales of the FIADS and the HADS total
score and similarly for the subscales of the WBQ.
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There was a significant positive correlation between disease severity and the HADS
depression score (rho = .611, p = .009, two-tailed) but no significant correlation
between disease severity and either HADS anxiety, HAD total score or any of the
WBQ subscales (see tables 3.10 & 3.11).
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Table3.10.Spearman'srhoco rel tionsf rCFdise severityndHADSsco .
CFdiseaseHADS severityHADSanxiedepressiontotal
Spearman'srhoCFdiseaseverityorrelationeffici t1.000.091611*' .439 Sig.(2-tailed).68900.046 N22171 HADSanxietyCorrelationefficie t.0911.00 .267858*' Sig.(2-tailed).689.3000 N22171 HADSdepressionCor latefficient.611*' 2671.00064 Sig.(2-tailed).0093 04 N17 HADStotalC rrel tionefficient.439* .858*' 664*'1.000 Sig.(2-tailed).046004 N2117 **•Correlationissignifica tatthe0.01lev l(2-tail d). *•Correlationissignifica tatthe0.05lev l(2-tail d).
Table3.11.Spearman'srhoco rel tionsf rCFdise sev rityndWBQsco e
CFdiseaseWBQ severitydepr ssionWBQanxiee gwell-b ng
Spearman'srhoCFdiseaseverityorr l tionCoeffici t1.000.277.092-.2819 Sig.(2-tailed).21268405176 N22 WBQdepressionCor latiefficie t.2771.000.719*' -.640*' 772 Sig.(2-tailed).212.0001 N22 WBQanxietyCorrelationefficient.092719*'1.00-.451* 587*' Sig.(2-tailed).68400035.0 4 N22 WBQenergyCorrelationfficie t-.281.640*' .451*1.000.707' Sig.(2-tailed).2050 13.000 N22 WBQwell-beingCorrelationefficient-.299.772*' 587' .707*'1.00 Sig.(2-tailed).1760004.00 N22 **■Correlationissignifica tatthe0.01lev l(2-tail d). *•Correlationissignifica tatthe0.05lev l(2-tail d).
Hypothesis 2 related analysis:
Pearson's correlation analysis was carried out to test the hypothesis that low
perceived control and high perceived consequences would be associated with higher
levels of anxiety and depression in both groups. Analysis was carried out
independently for the Type 1 diabetic group and the CFRD groups with the alpha
level set at p< .01 in order to reduce the chances of making Type 1 errors due to
multiple comparisons (Cohen, 1992).
Type 1 diabetes:
Consequences:
Greater perceived consequences were associated with the HADS depression (r =
.442, p = .004) and total scores (r = .456, p = .002) but not HADS anxiety (table
3.12). Similarly, associations approaching significance were found between
perceived consequences and the WBQ measure of depression (r = .359, p = .015) but
not WBQ anxiety (table 3.13). Thus higher levels of perceived consequences
amongst the Type 1 sample were associated with higher scores on measures of
depression. In the case of correlations r was taken as the effect size as recommended
by Cohen (1992). Correlations ranged from .36 to .46 indicating medium to large
effect sizes (Cohen, 1992).
Control:
A negative correlation approaching significance was found between the treatment
control dimension and the HADS measure of depression (r = -.389, p = .013) but not
anxiety (table 3.12). Similarly, perceived treatment control approached a significant
negative correlation with WBQ depression (r = -.355, p = .017) but not anxiety (table
80
3.13). Thus, patients' beliefs in higher levels of treatment control were associated
with lower levels of depressive symptomatology. Correlations were indicative of
medium effect sizes (Cohen, 1992).
Personal control was not significantly correlated with either the anxiety or depression
measures of the Hospital Anxiety and Depression Scale (HADS) or the Weil-Being
Questionnaire (WBQ).
Cystic Fibrosis Related Diabetes
No significant correlations were found, for the CFRD group, between illness
representations and anxiety and depression measures on the HADS or the WBQ at
the p < .01 significance level (tables 3.14 & 3.15). The lack of significant
correlations could be a function of the small sample size and consequently the
reduced power of this test. However, examination of the r values found that
correlation coefficients ranged between .025 and .332 on the HADS measure and
between .002 and .318 on the WBQ suggesting instead, that effect sizes were small
and non-significant findings in the CFRD group were not simply a function of the
smaller sample size.
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**•Correlationissignifica tatthe0.01lev l(2-tail d). *•Correlationissignifica tatthe0.05lev l(2-tail d).
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**■Correlationissignifica tatthe0.01lev l(2-tail d).
Predicting levels of anxiety and depression:
Stepwise multiple regression analysis was used to assess the role played by illness
representations in predicting levels of anxiety and depression. All illness
representation dimensions, except cause, as this was a categorical variable, were
entered into the analysis. All eight other illness representation dimensions; identity,
timeline acute/chronic, timeline cyclical, consequences, treatment control, personal
control, illness coherence and emotional representations were available to the model.
The Weil-Being Questionnaire subscales of anxiety and depression were used as
dependent variables as these had similarly been used elsewhere in the literature.
When regression analysis was performed for the CFRD group, no variables were
entered into the model therefore results given below relate to the Type 1 diabetes
group.
Regression analysis found depression in the Type 1 group to be significantly
predicted by both emotional representations and treatment control, and anxiety to be
predicted by emotional representations and beliefs in a more acute time course of the
illness (Table 3.16). The analysis was repeated but was subsequently only interested
in the role played by cognitive illness representations in the prediction of levels of
anxiety and depression. The emotional representations dimension was therefore
removed and only the cognitive illness representation dimensions entered into the
equation. Regression analysis subsequently found that depression was predicted by
consequences and treatment control and anxiety was predicted by both beliefs in an
acute and cyclical time course of the illness (Table 3.17).
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Table 3.17. Regression analysis to predict WBQ anxiety and depression from














































• Higher perceived consequences and lower perceived treatment control were
significantly associated with levels of depression, but not anxiety, in the Type
1 diabetic group.
• This study did not show significant correlations between illness
representations and psychological outcome in the Cystic Fibrosis related
diabetic group.
• Illness representations other than consequences and control were predictive of
levels of anxiety in the Type 1 group; beliefs in a more acute and cyclical
time course of illness were predictive of levels of anxiety in the Type 1
group.
• Emotional representations were predictive of both anxiety and depression in
the Type 1 group.
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Hypothesis 3
Differences will exist between staff and patients' illness representations on
dimensions of consequences and control.
Descriptive analysis - Illness Representations
A total of 17 staff completed and returned the questionnaire. This sample consisted
of 8 staff nurses, the ward charge nurse and 8 members of the multi-disciplinary
cystic fibrosis team. Means and standard deviations of the illness representation
dimensions of consequences, personal control and treatment control for both the
CFRD group and the staff group are given in table 3.18. Examination of the mean
scores of these dimensions shows that staff perceived moderate consequences for
their patients due to their diabetes and moderate levels of treatment control. In
addition, staff perceived that their cystic fibrosis patients had relatively high levels of
personal control over their diabetes.
Hypothesis 3 related analysis
Levene's test for equality of variance showed that there was heterogeneity of
variance therefore t-test analysis, which accounted for this violation, was performed
to test the hypothesis that differences would exist between staff and patients illness
representations on dimensions of consequences and control (Table 3.19). Two-tailed
t-tests compared differences in scores between the CFRD group and the staff group
on the illness representation dimensions of consequences, treatment control and
personal control. There was a significant difference between the groups on the
consequences dimension (t = -4.602, p <.001). Staff believed that their patients'
diabetes had significantly more consequences for the patient than the patients
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themselves did. There were no significant differences between the staff and patient
groups on perceived levels of treatment or personal control.
Conclusions:
• Staff perceived significantly greater consequences of a diagnosis of diabetes
in their patients than the patients themselves did.
• Statistically significant differences did not exist between the staff and patient
groups on perceived levels of treatment or personal control.
• The hypothesis that difference will exist between staff and patients illness
representations is partially supported.
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Table3.19.Independ ntS mplet-t st:Differenc sb twe nCFRDa dtaffgroupoIPQco quences,tr atm tntrolp rso al TdfSig(2-tailed)95%confidenceinterval LowerUpper IPQconsequences-4.60230.724.000-6.368-2.456 IPQpersonalcontro-1.09336.979.281-2.975.890 IPQtreatmentcontrol-.08128.056.936-2.1081.948
4. Discussion
Overview
The role of illness representations in the psychological well-being of patients with
insulin dependent diabetes was investigated in two different patient groups; patients
with Type 1 diabetes and patients with Cystic Fibrosis related Diabetes. Forty five
patients with Type 1 and 22 patients with CFRD completed measures relating to
perceived illness representations and psychological well-being. The aims of the
present study were to address three specific research questions: (1) to compare the
illness representations held by patients with Type 1 diabetes, with those held by
patients with Cystic Fibrosis related diabetes and to determine whether differences in
representations of consequences and control existed between groups (2) to investigate
the relationship between illness representations and psychological adjustment in
patients with insulin dependent diabetes and (3) to compare patients' perceptions of
illness with the perceptions of illness held by the hospital based, multi-disciplinary
team involved in their care. Results of the study are discussed in this section and
findings are compared with previous research reported in the literature.
Methodological limitations of the present study are considered. Clinical implications
of the results for the psychosocial care of patients with Type 1 and Cystic Fibrosis
related diabetes are discussed. Finally conclusions are drawn and directions for future
research are identified.
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4.1 Summary of Main Findings
Ql: Illness Representations of Diabetes
The Self-Regulatory model (Leventhal, Meyer & Nerenz, 1984) provides researchers
and clinicians with a framework that attempts to explain the variation in adjustment
and outcome to illness, by identifying the ways in which patients cognitively and
emotionally respond to the threat posed by illness. LeventhaTs self-regulatory model
proposes that in response to illness and other health threats, two parallel response
processes are activated. People develop both cognitive and emotional responses to the
threat of ill health. Patient's cognitive representations of illness are assessed along a
number of dimensions including identity (the label given to the illness and its
symptoms) cause (the perceived cause of the illness), timeline (the patient's beliefs
about the likely timeline of the illness ie is it acute/chronic, unpredictable),
consequences (the impact of the illness in physical and emotional terms), and
controllability (beliefs about how well the illness can be managed or cured). In
addition the patient's emotional response to illness is assessed.
The present study employed this framework to investigate the beliefs held by patients
about their illness, using the revised Illness Perceptions Questionnaire (Moss-Morris
et al, 2002). This study used a version of the questionnaire specifically developed for
use with patients with diabetes.
Type 1 Diabetes
Patients in the Type 1 diabetic group obtained scores on the different dimensions of
illness representations similar to those reported elsewhere, using the same measure,
with an adolescent Type 1 sample (Law et al, 2002). On the whole, the sample
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perceived their diabetes to be of chronic duration, they scored highly on the illness
coherence dimension and perceived high levels of personal control over their illness.
The Type 1 diabetic patients perceived moderate levels of treatment control over their
diabetes and moderate consequences of their illness. The consequences dimension of
the questionnaire used in this study consisted of questions relating to beliefs about the
seriousness of the illness, the impact of having diabetes on the patient's life, financial
consequences and the effect having diabetes has on relationships with others. As there
currently is no cure for diabetes, patients correctly identified their illness as having a
chronic course. High levels of illness coherence reflected a sense that patients had a
good understanding of their illness perhaps indicating that patients are well informed
about their disease. Beliefs regarding treatment control are likely to reflect an
informed and realistic appraisal of their illness. Treatment for Type 1 diabetes can
help patients to manage their condition and is important in order to prevent the onset
of complications, but ultimately it is not a cure. Treatment for this condition does
have its limitations and this appears to be reflected by the perceptions of treatment
control held by this patient sample.
Cystic Fibrosis related Diabetes
Investigation into the role of illness representations in the adjustment and outcome of
diabetes has a growing literature base, however this framework has not previously
been used to understand adaptation to diabetes in patients with cystic fibrosis. Scores
obtained on the illness representation dimensions for the cystic fibrosis related
diabetes sample in the current study showed largely similar results to those found in
the Type 1 group. These findings again appear to reflect the realistic factors
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associated with diabetes and suggest that the cystic fibrosis sample, like both the
adolescent and adult Type 1 groups, are well informed about their disease.
Differences between patient groups on perceptions of consequences and control
Consequences and Treatment Control
Findings from the present study show that there were no statistically significant
differences between the cystic fibrosis related diabetes group and the Type 1 diabetes
group on the illness representation dimensions of consequences or treatment control.
It was predicted that patients with CFRD would perceive more control and fewer
consequences of their diabetes than the Type 1 group. The fact that no significant
differences between groups were found on these dimensions perhaps emphasises that
although patients with a pre-existing illness do have experience of coping with the
limitations and management of a chronic condition, the increased burden of illness
consequent of a secondary diagnosis should not be ignored. However, it is possible
that there was insufficient statistical power in the present study to detect a difference
between groups that does exist in the population. A calculation of effect size suggests
that there was a medium effect of group, with Type 1 diabetic patients rating the
perceived consequences of diabetes higher than the CFRD group. A medium effect
size could be interpreted as clinically relevant and may reflect denial, minimisation or
a simple lack of awareness of the consequences of diabetes in the Cystic Fibrosis
sample.
Personal Control
It was initially predicted that patients with CFRD would perceive greater personal
control over their diabetes than Type 1 diabetic patients. However, participants in the
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Type 1 diabetic group perceived significantly more personal control over their
diabetes than those with cystic fibrosis related diabetes. This finding was in
opposition to that hypothesised. An estimate of effect size indicated a large effect of
group suggesting that this is a clinically relevant finding and therefore warrants
further investigation.
Illness representation dimensions are likely to be inter-related and it is difficult to
understand a single attribute without an understanding of how it may be implicitly or
explicitly linked to others (Hampson, 1997; Leventhal et al, 1997). Reference to the
patients' perceived causes of diabetes may give us some insight into this unexpected
finding regarding personal control.
Whereas the Type 1 group gave a wide range of causes for the onset of their diabetes,
68% of the CF sample detailed having pre-existing cystic fibrosis as the primary cause
of their diabetes. Other than having CF, only 3 other causes were given by the CF
group, namely, chance/badluck, diet and germ/virus. Infections and dietary control
are factors that play major roles in the course and management of Cystic Fibrosis and
the decision to start insulin in patients with cystic fibrosis related diabetes may be a
result of declining lung function or detrimental decreases in body weight (Lanng et al,
1994b). An abnormal glucose tolerance test alone, will not necessarily result in the
need for insulin treatment in CF patients, thus the CF patients who attributed their
diabetes to diet or germ/virus, may therefore be indirectly attributing the cause of their
diabetes to the course of their cystic fibrosis. A closer examination of the
circumstances surrounding the start of insulin therapy in patients was beyond the
scope of the present study. However, such investigation may uncover a temporal
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relationship between an exacerbation of the patient's CF disease, or weight loss and
the commencement of insulin that could explain the causes given.
The majority of patients with CFRD correctly identified the cause of their diabetes as
being a result of the progression of their cystic fibrosis. Although management of CF
is aimed at slowing the progression of the disease, patients' conditions will deteriorate
and they do face a foreshortened lifespan. For some, the onset of cystic fibrosis
related diabetes is indicative of their condition 'going downhill' (Lowton & Gabe,
2003). The finding that the CFRD groups perceived less control over their diabetes
than the Type 1 group may suggest that CF patients perceive their diabetes as a
largely uncontrollable consequence of the progression of their cystic fibrosis whereas
the Type 1 group have a distinct disease which they may be more likely to perceive as
controllable.
In addition challenges occur due to the complications of the cystic fibrosis disease as
patients with a secondary diagnosis of diabetes are often malnourished, requiring
overnight enteral tube feeding resulting in adjusted insulin regimes (Wilson et al,
2000). Dietary intake can vary greatly from day to day in CF patients because of
pulmonary and gastrointestinal disease therefore a flexible regimen is usually
required. In addition patients with CFRD may become tremendously insulin resistant
when they are acutely ill and may need considerably larger insulin doses than usual
(Moran, 2002). In light of these factors it may be understandable that individuals with
cystic fibrosis related diabetes perceive lower levels of personal control over their
diabetes than those individuals with type 1 diabetes; their treatment regimen is less
well defined and the additional complications due to their cystic fibrosis disease
97
impact significantly on their diabetic control. Clinically it is therefore important that
CFRD is managed in joint clinics with specialists from both the cystic fibrosis and
diabetic services working in collaboration.
Q2: The association between consequences/control and anxiety and depression
The self-regulatory model has been investigated in terms of the role of illness
representations in predicting adaptive outcome. Studies focussing on a variety of
different illnesses have provided evidence that perceived consequences and control of
illness are important factors influencing medical and psychological outcome
(Heijmans, 1998; Jopson & Moss-Morris, 2003; Scharloo et al, 1998). In the
literature investigating the role of illness representations and their association with
psychological well-being in diabetes, perceived control has been found to be a
significant predictor of positive perceptions of quality of life (Watkins et al, 2000;
Law et al, 2002), and perceived consequences have been found to be significant
predictors of anxiety and depression (Edgar & Skinner, 2003; Law et al, 2002;
Skinner et al, 2000).
The present study aimed to investigate the relationship between diabetes illness
representations and psychological well-being in both a Type 1 diabetic sample and a
cystic fibrosis related diabetic sample. To the author's knowledge, this relationship
had never previously been investigated in a CFRD sample.
The present study added further evidence to the literature in support of the association
between illness representations and psychological outcome measures. However when
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these relationships were examined distinctly for each diabetic group the relationships
between these factors varied depending on the underlying illness.
Type 1 diabetes
For the Type 1 group, in line with previous research, fewer perceived consequences
and greater perceived levels of control were associated with lower levels of
depression, however they were not significantly correlated with levels of anxiety. The
contribution of the consequences and treatment control measures in the prediction of
depression was underlined in multiple regression analysis, which found that a
combination of these two dimensions accounted for a significant amount of the
variance in levels of depression amongst the Type 1 patient sample. Multiple
regression analysis suggested that cognitive illness representations other than
consequences and treatment control were predictive of levels of anxiety. Perceived
daily variability of diabetes as well as beliefs that diabetes was not a chronic condition
were predictive of levels of anxiety. When emotional representations, ie the patient's
direct emotional response to their diabetes, was added to the model, it was found to be
the greatest predictor of levels of both anxiety and depression in the Type 1 sample.
Cystic Fibrosis related Diabetes
A different pattern of relationships was found within the CFRD sample. Unlike the
Type 1 sample, neither perceived consequences nor control of diabetes was associated
with anxiety or depression. Examination of the effect sizes would suggest that this
finding was not just an artefact of the smaller sample size.
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The contribution of illness representations other than consequences and control
In the CFRD group, although results were not significant, examination of the
correlation coefficients showed that the timeline cyclical dimension was associated
with poorer psychological well-being. Patients who perceived the course of their
diabetes to vary from day-to-day, therefore perhaps feeling that their diabetes was
unpredictable, were more likely to score negatively on measures of psychological
well-being. Interestingly there appeared to be no relationship between the direct
emotional response to diabetes and measures of psychological well-being in this
group. It is difficult to draw any conclusive reasons for this from the data however
this may be a function of the CF patients failing to draw a clear distinction between
their diabetes and the CF disease or it may reflect the fairly good overall adjustment
of the cystic fibrosis sample.
Q3: The role of social context
It has been recommended that the self-regulatory framework be extended into the
social context (Law, 2002; Leventhal et al, 1997). Leventhal's model acknowledges
the role of social factors in the appraisal of illness, yet despite this, there has been
relatively little research focussing on the impact of the social context on the appraisal
and outcome of illness. Studies that have investigated the association between the
respective beliefs held by patients, their family members or health care providers and
psychological outcome have shown that dissimilarity in views of illness held by
different individuals can contribute to coping and adaptive outcome (Heijamns et al,
1999;Heijmans et al, 2001 Law, 2002, Richards et al, 2004; Salewski, 2003). It has
further been suggested that differences between the perceptions of illness held by
patients and their health care providers about the stressors faced by patients with
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chronic illness may lead to misunderstandings and disrupt effective communication
(Heijmans et al, 2001). The present study aimed to investigate if differences in illness
representations existed between patients with CFRD and the health care staff involved
with their care.
The findings of the present study supported the results obtained by Heijmans et al
(2001) that patients and health care providers can diverge in the way they think about
illness. The staff group perceived significantly more consequences of diabetes for
their patients than the patients themselves did, however, beliefs relating to control
held by patients and staffwere similar.
This is an interesting finding as anecdotally staff tended to assume that the secondary
diagnosis would bare little additional impact on the patient. A closer examination of
the factors which make up the consequences dimension of the IPQ-R may give us
some insight into the nature of the divergence in beliefs between the two groups.
Examination shows that 100% of staff respondents agreed with the statements that the
patients' diabetes is a serious condition and that it had major consequences on the
individuals' lives. Eighty two percent and 41% of patient participants agreed with
these statements respectively. Again, this highlights that CFRD patients are perhaps
minimising or are simply ill-informed about the consequences of their diabetes.
When asked about their views on the impact of their diabetes on relationships with
others, 22% of the CFRD patient group agreed that their diabetes caused difficulties
for those close to them, whereas 41% of staff perceived that the patients' diabetes
would cause difficulties in this way. However, both the staff and patient groups had
similar views that diabetes did not incur serious financial consequences for the patient
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The discrepancy in perceptions between staff and patients regarding the seriousness of
a diagnosis of diabetes in CF patients may reflect on one hand, as has been suggested
elsewhere (Heijmans et al, 2001), that perceptions of illness held by staff are more
congruent with medical knowledge than the patients' subjective experience.
Alternatively, this may reflect a lack of information in the patient group or, that to
some extent patients deny or minimize the seriousness of their condition in an effort
to maintain a positive attitude to their health. Illness beliefs regarding control did not
differ between the two groups, which would suggest that both groups recognised the
limitations to control diabetes in this patient population. Heijmans' (2001) proposal
that diverging views between patients and health care providers may lead to
misunderstandings and disrupt communication highlights the importance of
recognising and acknowledging the beliefs held by both groups in the continuing care
of individuals with chronic illness. The current study supports Heijmans findings that
incongruent beliefs do exist although this study did not directly investigate the impact
of similar/dissimilar view on psychological, behavioural or medical outcome. This
may be an avenue to explore in future research.
4,2 Methodological Limitations
In interpreting these findings we must consider limitations to the present study.
Sample Size
The limited number of participants recruited to this study left the study vulnerable to
the effects of low statistical power. To control for the effects of conducting multiple
tests of statistical significance the alpha level ie. the probability of detecting an effect
when in fact none exists, was set at the more stringent value of 0.01. This more
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conservative level of statistical probability meant that the sample sizes in this study
were relatively small.
Sample Representativeness
Response rates of 71% and 47% were achieved in the CFRD group and the Type 1
group respectively. Considering that research using postal questionnaires often has
around a one-third non-response rate (Dillman, 2000) the rate achieved for the CFRD
group was consistent with that expected, however, the response rate in the Type 1
group was relatively low. This may be a function of the closer contact the researcher
had with the CFRD group and therefore their increased willingness to participate. The
presence of non-responders immediately introduces a bias into the results as non-
responders may differ from responders on a number of factors including interest,
motivation, psychological state or disease state.
The present study did not have access to information to assess whether or not
responders differed significantly from non-responders on these factors therefore the
generalizability of the findings should be interpreted with caution. Results regarding
the association between illness representations and psychological well-being replicate
other studies that have found similar association between these measures in both
adolescent and adult, Type 1 and Type 2 diabetic populations. However, these
associations have not previously been investigated in a CFRD population therefore




The cross-sectional nature of this study does not allow causal inferences to be made.
Although correlational relationships allow us to establish that two factors covary they
do not allow us to establish the temporal or causal relationships between them. Due
to the time-scale limitations of this study a prospective study was not feasible.
However without a prospective design, the study is unable to capture the dynamic
interaction between illness representations and psychological outcome or the recursive
nature of the self-regulatory model.
Recent studies have questioned support for the self-regulatory model in its ability to
predict coping and self-management behaviours in diabetic patients although they
have supported the role of illness representations in the psychological presentation of
these patients (Edgar & Skinner, 2003; Law et al, 2002). The current study is unable
to make conclusive statements either in support or opposition to the theoretical
framework of the Self-Regulatory Model as it did not look at the mediating role of
coping in psychological adjustment nor did it investigate self-management
behaviours. This may be an interesting area of investigation for future research.
Critique of Measures Used
The Hospital Anxiety and Depression Scale (HADS)
The HADS scale is a measure of anxiety and depression used widely with medical
patients both clinically and in research. The scale provides a briefmeasure of anxiety
and depression which may be useful for screening and monitoring psychological
distress. The HADS may be the most useful measure for monitoring levels of
psychological distress in CFRD patients, as it avoids items relating to somatic
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manifestations of depression and anxiety which could lead to elevated scores in
populations of patients suffering from a medical condition. No disease specific
measure of anxiety or depression is currently available for CFRD patients. The
HADS measure is currently being used for routine monitoring with all CF patients in
the service in Edinburgh.
The Well-Being Questionnaire (WBQ)
The WBQ is a measure that was developed specifically for use with diabetic patients
and has been used in previous research interested in the association between illness
representations and psychological well-being. Although the scale has been shown to
have good validity and reliability with a diabetic population, its validity with a CFRD
population may be questionable. This is perhaps highlighted by the variable
association found between measures on the HAD scale and measures on the WBQ
scale for the CFRD group. As the WBQ was developed as a disease specific measure,
a more general measure of anxiety and depression, such as the HADS, may be more a
reliable measure of psychological outcome in the CFRD population. Either the WBQ
or the HADS may be appropriate for routine psychological monitoring with the Type
1 diabetic group.
The Illness Representation Questionnaire-Revised (IPQ-R)
In this study the diabetes, disease-specific, version of the IPQ-R was used. This
questionnaire referred explicitly to the patient's diabetes, which was important in
order to address the research questions. As the CFRD group had a pre-existing
chronic illness, the use of this questionnaire enabled us to be fairly confident that the
participants were answering the questions with reference to their diabetes opposed to
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their CF disease as a whole. However, the results of this study would suggest that
CFRD patients largely perceive their diabetes as a consequence or progression of the
CF disease and therefore this may, in fact, be a fairly arbitrary distinction for these
patients.
To the author's knowledge, the role of illness representations in cystic fibrosis have
not previously been investigated, therefore further research is required to validate the
use of this scale with this clinical population. However previous studies have shown
this measure to have good reliability (Moss-Morris et al, 2002) and it has been used
elsewhere with diabetic populations (Law, 2002). The present study used this
measure in order to allow comparison with previous research.
Use of a questionnaire to assess illness representations does not allow the study to
access patient self-generated illness representations. It could be argued that this
imposes a restriction on patients and therefore by design may be excluding key
dimensions that patients themselves view as important. In his original work,
Leventhal conducted interviews with patients, which he argued allowed them to
generate their own beliefs rather than having a pre-determined researcher oriented
framework imposed upon them. However, ensuing research has consistently provided
support for the dimensions subsequently included in the IPQ and therefore this allows
us to take some confidence in the relevance of the dimensions used.
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4.3 Discussion of Clinical Implications
The findings emphasise that attention to the psychological factors involved in
adapting to chronic illness must not be ignored and that routine monitoring of
patients' psychological as well as their physical state should be encouraged.
Incidence of Anxiety and Depression
Findings from the current study show that the incidence of psychological distress, in
concordance with previous literature, is relatively high in the Type 1 diabetic sample
(Anderson et al, 2001a; Jacobson, 1996 Jacobson et al, 2002; Lustman, 1988; Peyrot
& Rubin, 1997). Thirty-one percent of the sample experienced levels of anxiety that
were at least borderline for clinical significance. However, the reportedly high levels
of depression in Type 1 diabetic samples was not supported by the current study as
only 7% of the sample scored above the cut off indicating a clinically significant level
of depression. This unexpectedly low figure may be a function of the
representativeness of the study sample; perhaps patients who were experiencing more
depressive symptomatology were less likely to participate. As levels of psychological
distress are not currently routinely monitored within the diabetic clinic, there was no
way of accessing this information to corroborate or reject this theory.
Within the cystic fibrosis related diabetic sample 14% scored above the cut-off level
indicating levels of anxiety that were at least borderline for clinical significance and
9% scored above the cut-off indicating similar levels of depression. This is
considerably lower than the 20-25% prevalence detailed for patients with a chronic
medical condition and supports previous findings that have provided evidence of
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relatively good psychological adaptation in adult CF populations (Anderson et al,
2001b; Blau et al, 2003; Cowen et al, 1984).
An important clinical point to note, is that where patients, in either group, experienced
levels of depression that were within the clinical range they were also likely to
experience higher levels of anxiety. Comorbidity in depression is widely recognised
and it is often accompanied by concurrent or recent anxiety (Hammen, 2001). The
implication of this is that comorbidity of depression can imply worse functioning
(Lewinsohn, Rohde & Seeley, 1995) and in the context of chronic disease, this may
have significant behavioural, medical and psychological implications.
Theoretical models in clinical health psychology are only of value to the extent that
they can guide assessment and intervention (Law, 2002). It is therefore important in
conducting research that the clinical implications of the findings are considered. In
assessing the clinical implications of the present study we will consider the two
patient groups independently.
Type 1 Diabetes
The findings concerning the Type 1 diabetic group supported previous research that
had found an association between illness representations held by patients and their
psychological well-being. In particular, cognitive representations concerning
perceptions of consequences and control were associated with patients' levels of
psychological distress. As these results replicated findings from earlier studies, this
association would appear to be a fairly robust, suggesting that where appropriate,
interventions should be targeted at optimising patients' perceptions of control and
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minimising perceived consequences. There has been a shift in diabetic care from the
'gold standard' of good glycaemic control to a management strategy that takes
account of multivariate factors (Law, 2002). Good diabetic care should take account
not just of blood glucose control, and the medical aspects of management but also of
the psychological and quality of life issues that patients with diabetes face.
In addition to the cognitive response to illness, the present study highlighted the
importance of acknowledging the patients' emotional response to illness and its
association with levels of more general psychological well-being. Such findings
would suggest that clinically it is important to assess and recognise both the patients'
cognitive and emotional response to illness and the coping skills they possess to
manage these. The relatively high levels of psychological distress that are often
reported in this patient group would suggest that availability of psychological services
to this group is an important aspect of their ongoing care.
Psychological approaches/interventions that explicitly assess patients' illness
representations could potentially provide health care workers with a fruitful avenue to
management, where psychological factors are not only important in terms of
compliance with treatment but more generally in optimising patients' quality of life.
Interventions aimed at modifying maladaptive cognitive and emotional
representations of illness and developing adaptive coping strategies may prove to be
beneficial. A cognitive behavioural approach to treatment in diabetes, outlined by
White (2002), aims to promote effective self-management of the disease, thereby
optimising levels of control, and to minimise psychological problems which arise as a
direct result of the disease and its consequences. Although this approach has so far
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not been systematically evaluated in a Type 1 population, results of a randomised
control trial of Cognitive Behaviour Therapy in patients with Type 2 diabetes showed
encouraging results (Lustman, Griffith et al, 1998). This psychological approach may
prove a valuable resource in diabetes management.
Cystic Fibrosis related Diabetes
In terms of the clinical implications for the cystic fibrosis related diabetic group, the
findings from the present study suggest that patients appear to perceive their diabetes
as a secondary consequence of their cystic fibrosis as opposed to a distinct illness in
its own right. This would suggest that a collaborative team approach to treatment
involving attendance by both the CF and diabetic teams at a joint clinic, ideally in the
same location, would provide the optimal approach to care as suggested by Moran
(2002). Low perceived levels of personal control, perhaps aggravated by the lack of
well-defined treatment protocols, may be addressed by encouraging the medical
teams, where possible, to collaborate with the patients in determining plans for self-
management.
Findings from the current study showed that as the CF disease becomes more severe,
patients become more vulnerable to depression. With progressing disease, patients'
lung function deteriorates, they become more susceptible to infections, requiring more
frequent intra-venous antibiotics, and limitations imposed by the disease become more
acute. Findings related to the impact of disease severity on psychological functioning
remain inconclusive. Anderson and colleagues (2001b), in support of the current
study's findings, found that better lung function was predictive of better psychological
functioning. However, disease severity per se was not found to be associated with
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psychosocial scores by Britto, Kotagal, Hornung, Atherton, Tsevat & Wilmott (2002)
who suggested that pulmonary exacerbations rather then lung function were
associated with decreased psychosocial functioning. Nevertheless, findings do
suggest that as the patient's disease progresses or their condition deteriorates, they
may be more susceptible to mood problems. As the disease progresses the burden of
the disease increases. It is important to consider this in light of the fact that as
individuals with cystic fibrosis live longer, a secondary complication of diabetes is
becoming more prevalent and this condition adds to the burden of illness. Monitoring
should include not just assessment of the patients' physical state but also recognition
of the psychological impact of their progressing disease.
The importance of psychosocial care in cystic fibrosis has been recognised for some
time and guidelines set down by the Cystic Fibrosis Trust (2002) highlight the need
for accessible psychological care for patients in this population. The monitoring and
assessment of patient's psychological state may be particularly important at times
when the burden of their illness is increasing. This may also be a time when effective
communication with staff is paramount.
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4.4 Conclusions and Directions for Future Research
This study found that an understanding of the illness representations held by patients
could be a valuable tool in the ongoing care of individuals with a chronic medical
condition.
The role of illness representations in the psychological well-being of adults in two
different patient groups, who required management of insulin-dependent diabetes, was
investigated. Results from the Type 1 diabetic group found that illness
representations were predictive of levels of anxiety and depression. As this finding
replicates results found in previous studies, it emphasises the potential benefit of
assessing patient's illness representations and addressing maladaptive beliefs, in the
psychological approach to the treatment of anxiety and depression in this patient
population. Perceived consequences and levels of treatment control were found to be
particularly predictive of levels of depression suggesting that interventions that
specifically targeted these beliefs may prove beneficial.
This study did not investigate adherence to treatment and it excluded patients who had
multiple diabetic complications. Future research interested in the relationship
between illness representations and outcome in adults with diabetes may benefit from
widening the inclusion criteria to include patients who have developed multiple
complications as a result of their diabetes and who perhaps therefore have a less well
controlled condition. In addition, the relationship between illness representations and
psychological well-being would be better understood using a prospective study
design.
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No significant statistical difference in the perceived consequences of diabetes was
found between patients in the Type 1 or CFRD groups. This suggests that despite
cystic fibrosis patients having experience of coping with the limitations and self-
management demands of a pre-existing chronic illness, the increased burden of a
secondary diagnosis should not be ignored. However, an estimate of effect size
suggests that a clinically significant difference in the perception of the consequences
of diabetes was apparent. This may reflect either a denial or minimisation of the
consequences of diabetes in the CFRD group or simply a lack of awareness of the
possible consequences of diabetes in the cystic fibrosis sample.
The majority of patients in the CFRD group attributed the cause of their diabetes to
their pre-existing illness. Contrary to initial prediction, the CFRD group perceived
lower levels of personal control than the Type 1 group. This study would suggest that
the cystic fibrosis patients' understanding of their diabetes as a largely uncontrollable
consequence or progression of their cystic fibrosis, rather than a distinct illness in its
own right, may help to explain their beliefs of lower levels of control.
The recruitment of patients with cystic fibrosis related diabetes to this study was
limited due to the relatively small and finite numbers of patients with this condition in
the general population. The results should therefore be interpreted with caution as
insufficient statistical power may have contributed to non-significant results.
However, as findings from this study suggested that, on the whole, the CFRD group
believed their diabetes to be a consequence of their cystic fibrosis, the focus on just
one aspect of their illness ie. diabetes, may have been too narrow to allow for
significant associations between illness representations and psychological well-being
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to have become apparent. As individuals with cystic fibrosis live longer, the
numbers of people with the condition increases, and the challenge for patients of
living with this chronic illness is prolonged. Further investigation into the role of
illness representations in the adaptive outcome of patients with cystic fibrosis may
therefore provide a valuable contribution in efforts to improve the quality of life for
these patients.
The present study suggests that it may be impossible to separate out the impact of one
aspect of cystic fibrosis (eg. diabetes) from the condition as a whole. Development of
a scale that allows assessment of patient's representations of their cystic fibrosis more
widely may therefore be useful. The role of illness representations in adaptive
outcome has been found to be significant in a number of different chronic illnesses.
This would suggest that perhaps a coordinated multi-centre study, that would allow
for access to larger numbers of participants with cystic fibrosis, may be appropriate in
order for these factors to be investigated further in this patient population.
An important aspect of the current study is that it adds to the limited literature
focussed on adults with cystic fibrosis and it acknowledges one of the additional
challenges they face as they live longer with their disease. For CFRD patients,
management of diabetes adds to the burden of what is already a complex and
demanding condition. Although, as a group, cystic fibrosis patients appear to be
relatively well psychologically adjusted, there remain individuals who are vulnerable
to psychological distress and due to the dynamic and progressive nature of the
disease, this distress may become more apparent at certain points upon the patient's
journey. Routine psychological monitoring, assessment and where appropriate,
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intervention are therefore necessary elements in the overall care of patients in this
population. Routine contact with the psychologist is carried out with all attenders at
the Cystic Fibrosis clinic at the authors place of work. This allows for regular
monitoring, the opportunity to establish trusting relationships, and, where necessary,
prompt action should this be required. In addition, it allows the multi-disciplinary
team to consider all appropriate factors in the management of their patients who suffer
from this multifaceted and challenging illness.
Leventhal's self-regulatory model provided the theoretical framework to this study.
However, as the study did not look at the mediating role of coping in adaptive
outcome, no conclusive results can be drawn, from this study, in support of or
opposition to the original model. Further research that investigates coping strategies
as well as illness representations and adaptive outcome is required before conclusions
regarding the validity of this theoretical model can be made. Nevertheless, the
importance of illness representations in exerting a direct influence on psychological
outcome was supported. This suggests, as proposed by Leventhal, that the ways in
which an individual represents and responds to the threat carried by illness, are
important in psychological outcome.
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Patient Views AboutDiabetes: Information for patients
with cystic fibrosis related diabetes (requiring insulin)
You are being invited to take part in a research study. Before you decide to
participate it is important for you to understand why the research is being done and
what it will involve. Please take time to read the following information carefully and
discuss it with others if you wish. Ask us if there is anything that is not clear or if you
would like more information.
What is the study about?
The study is being carried out to find out more about living with insulin dependent
diabetes. We are interested in the way in which people think about their diagnosis of
diabetes, and how this affects the way they feel. The study aims to better our
understanding of the impact of a diagnosis of diabetes on patients' lives.
Why have I been chosen to take part?
This study is interested in the views ofpatients with insulin dependent diabetes. We
are keen to compare the experience of two groups ofpatients:
(1) Patients whose diabetes is secondary to cystic fibrosis (CF), a genetic disease
that causes respiratory (chest) problems and other medical complications that
can be life-threatening.
(2) Patients who have insulin dependent diabetes (Type 1 diabetes) but no other
serious medical conditions.
All patients registered with the Adult Cystic Fibrosis Service at the Western General
Flospital, Edinburgh, who have a secondary diagnosis of insulin dependent diabetes
will therefore be invited to take part in the study. A group of patients of similar age
and sex to this group, but who attend the diabetic clinic (Type 1 diabetes patients) will
also be invited to participate.
What do I have to do if I take part?
If you agree to take part in the study you will be asked to fill out several
questionnaires when you next attend clinic. You will only be required to complete
these questionnaires on one occasion.
Do I have to take part?
No. It is up to you to decide whether or not to take part. If you decide to take part
and later wish to withdraw from the study you are free to do so at any time. A
decision to withdraw, or not to take part, will not affect your treatment or the standard
of care you receive in any way.
Headquarters:
St. Roque, Astley Ainslie Hospital, 133 Grange Loan, Edinburgh EH9 2HL
Chairman Garth Morrison CBE
Chief Executive Murray Duncanson
What are the possible benefits of taking part?
The information provided by participants may improve our understanding of the
impact of diabetes on patients' lives. We hope this information will improve the
support available when needed, in future.
Are there any disadvantages to taking part?
It is unlikely that you will experience any disadvantages as a result of taking part in
the study. If however you did have any problems (for example, with filling in the
questionnaires) please let the researcher know so that they can offer you some help or
discuss any problems.
Will the information I give be confidential?
The information you provide for this study will be kept strictly confidential and only a
number will be used to identify you. Your consultant and GP will be informed that
you are taking part in this study.
What will happen to the results of this study?
The results of the study may be published when the study is completed. All
information will have been collected by Summer 2004. Published reports will not
include your name or any other information that will identify you.
Who can I contact for more information?
If you have any questions about the study or wish to discuss the study
informally, please contact Paula Weeple, Trainee Clinical Psychologist with
the CF Team, at the CF Office on 0131 537 1762.
If you wish to speak to someone not directly involved in the study for advice,
you may contact an independent advisor who will try to deal with any queries.
Dr Ron Fergusson has agreed to be the independent advisor for this study and
can be contacted on 0131 537 1779.
Should you agree to participate in the study you will be given a copy of this
information sheet to keep and will be required to complete the attached consent form.
Thank you for taking the time to read this information sheet.
CFRD patientinfo version 2 (CF) 28/01/04




Patient Views About Diabetes: Information for patients
with Type 1 (insulin dependent) diabetes.
You are being invited to take part in a research study. Before you decide to
participate it is important for you to understand why the research is being done and
what it will involve. Please take time to read the following information carefully and
discuss it with others if you wish. Ask us if there is anything that is not clear or if you
would like more information.
What is the study about?
The study is being carried out to find out more about living with insulin dependent
diabetes. We are interested in the way in which people think about their diagnosis of
diabetes, and how this affects the way they feel. The study aims to better our
understanding of the impact of a diagnosis of diabetes on patients' lives.
Why have I been chosen to take part?
This study is interested in the views ofpatients with insulin dependent diabetes. We
are keen to compare the experience of two groups of patients:
(1) Patients whose diabetes is secondary to cystic fibrosis (CF), a genetic disease
that causes respiratory (chest) problems and other medical complications that
can be life-threatening.
(2) Patients who have insulin dependent diabetes (Type 1 diabetes) but no other
serious medical conditions.
All patients registered with the Adult Cystic Fibrosis Service at the Western General
Hospital, Edinburgh, who have a secondary diagnosis of insulin dependent diabetes
will therefore be invited to take part in the study. A group of patients of similar age
and sex to this group, but who attend the diabetic clinic (Type 1 diabetes patients) will
also be invited to participate.
What do I have to do if I take part?
If you agree to take part in the study you will be asked to fill out several
questionnaires when you next attend clinic. You will only be required to complete
these questionnaires on one occasion.
Do I have to take part?
No. It is up to you to decide whether or not to take part. If you decide to take part
and later wish to withdraw from the study you are free to do so at any time. A
decision to withdraw, or not to take part, will not affect your treatment or the standard
of care you receive in any way.
Headquarters:
St. Roque, Astley Ainslie Hospital, 133 Grange Loan, Edinburgh EH9 2HL
Chairman Garth Morrison CBE
Chief Executive Murray Duncanson
What are the possible benefits of taking part?
The information provided by participants may improve our understanding of the
impact of diabetes on patients' lives. We hope this information will improve the
support available when needed, in future.
Are there any disadvantages to taking part?
It is unlikely that you will experience any disadvantages as a result of taking part in
the study. If however you did have any problems (for example, with fdling in the
questionnaires) please let the researcher know so that they can offer you some help or
discuss any problems.
Will the information I give be confidential?
The information you provide for this study will be kept strictly confidential and only a
number will be used to identify you. Your consultant and GP will be informed that
you are taking part in this study.
What will happen to the results of this study?
The results of the study may be published when the study is completed. All
information will have been collected by Summer 2004. Published reports will not
include your name or any other information that will identify you.
Who can I contact for more information?
If you have any questions about the study or wish to discuss the study
informally, please contact Paula Weeple, Trainee Clinical Psychologist with
the CF Team, at the CF Office on 0131 537 1762.
If you wish to speak to someone not directly involved in the study for advice,
you may contact an independent advisor who will try to deal with any queries.
Dr Ron Fergusson has agreed to be the independent advisor for this study and
can be contacted on 0131 537 1779.
Should you agree to participate in the study you will be given a copy of this
information sheet to keep and will be required to complete the attached consent form.
Thank you for taking the time to read this information sheet.
CFRD patientinfo version 2 (D) 28/01/04




Patient andStaff Views about Diabetes: Information for Staff
You are being invited to take part in a research study. Before you decide to
participate it is important that you understand why the research is being done and
what it will involve. Please take time to read the following information carefully and
discuss it with others if you wish. Ask if there is anything that is not clear or if you
would like more information.
What is the study about?
The study is being carried out to find out more about the patients' experience of living
with insulin dependent diabetes. We are interested in the way in which patients think
about their diagnosis of diabetes, and how this affects the way they feel. The study
aims to better our understanding of the impact of a diagnosis of diabetes on patients'
lives.
The study is also interested in staff views about the impact of diabetes on patients'
lives and to what extent patient and staffperceptions of the impact of a diagnosis of
diabetes are similar.
Why have I been chosen to take part?
All members of the Cystic Fibrosis team and the Respiratory Ward staff at the
Western General Hospital are being invited to take part.
What do I have to do to take part?
If you agree to take part in the study you will be asked to complete one short
questionnaire. You will only be required to complete this questionnaire on one
occasion.
Will the information I give be confidential?
The information you provide for this study will be kept strictly confidential and only a
number will be used to identify you.
Should you agree to participate in the study you will be given a copy of this
information sheet to keep and will be required to complete a consent form.
Thank you very much for taking the time to read this information sheet.
Headquarters:
St. Roque, Astley Ainslie Hospital, 133 Grange Loan, Edinburgh EH9 2HL
Chairman Garth Morrison CBE
Chief Executive Murray Duncanson
Appendix B
The Weil-Being Questionnaire
Please circle a number on each of the following scales to indicate how
often you feel each phrase has applied to you in the past few weeks:
all not
the time at all
1. I feel that I am useful and needed 3 2 10
2. I have crying spells or feel like it 3 2 10
3. I find I can think quite clearly 3 2 10
4. My life is pretty full 3 2 10
5. I feel downhearted and blue 3 2 10
6. I enjoy the things I do 3 2 10
7. I feel nervous and anxious 3 2 10
8. I feel afraid for no reason at all 3 2 1 0
9. I get upset easily or feel panicky 3 2 10
10.1 feel like I'm falling apart and
going to pieces 3 2 10
11. I feel calm and can sit still easily 3 2 10
12.1 fall asleep easily and get a good
nights rest 3 2 10
13.1 feel energetic, active or vigorous 3 2 10
14.1 feel dull or sluggish 3 2 10
15.1 feel tired, worn out, used up, or
exhausted 3 2 10
16. I have been waking up feeling fresh
and rested 3 2 10
17. I have been happy, satisfied, or pleased
with my personal life 3 2 10
18.1 have felt well adjusted to my life
situation 3 2 10
19.1 have lived the kind of life I wanted to 3 2 10
20.1 have felt eager to tackle my daily
tasks or make new decisions 3 2 10
21.1 have felt I could easily handle or
cope with any serious problem or major
change in my life 3 2 10
22. My daily life has been full of things that
were interesting to me 3 2 10
Please make sure that you have considered each of the 22 statements and
have circled a number on each of the 22 scales.
© September 1993; Dr Clare Bradley, Diabetes Research Group, Royal Holloway,






Clinicians are aware that emotions play an important part in most
illnesses. If your clinician knows about these feelings she or he will
be able to help you more.
This questionnaire is designed to help your clinician to know how
you feel. Ignore the numbers printed on the left of the questionnaire.
Read each item and underline the reply which comes closest to how
you have been feeling in the past week.
Don't take too long over your replies; your immediate reaction to
each item will probably be more accurate than a long thought-out
response.
I feel tense or 'wound up':
Most of the time
A lot of the time
From time to time, occasionally
Not at all
I still enjoy the things i used to enjoy:
Definitely as much
Not quite so much
Only a little
Hardly at all
I get a sort of frightened feeling as if something awful is
about to happen:
Very definitely and quite badly
Yes, but not too badly
A little, but it doesn't worry me
Not at all
(continued overleaf)
THE HOSPITAL ANXIETY AND DEPRESSION SCALE
o
c
I can laugh and see the funny side of things:
As much as I always could
18
■c Not quite so much now
(0
^ Definitely not so much now
c
o
« Not at all
32
o
Worrying thoughts go through my mind:
A great deal of the time
A lot of the time






Most of the time





I feel as if I am slowed down:


























































I have lost interest In my appearance:
Definitely
I don't take as much care as I should
I may not take quite as much care
I take just as much care as ever





I look forward with enjoyment to things:
As much as ever I did
Rather less than I used to
Definitely less than I used to
Hardly at all










Now check that you have answered all the questions
For office use only:
D :□ Borderline 8-10
A :□ Borderline 8-10
© Zigmond and Snaith, 1983. From 'The Hospital Anxiety and Depression
Scale', Ada Psychiatrica Scandinavica 67, 361-70. Reproduced by kind
permission of Munksgaard international Publishers Ltd., Copenhagen. This
measure is part of Assessment: A Mental Health Portfolio, edited by Derek
Milne. Once the invoice has been paid, it may be photocopied for use
within the purchasing institution only. Published by The NFER-NELSON
Publishing Company Ltd, Darville House, 2 Oxford Road East, Windsor,
Berkshire SL4 1DF, UK. - Code 4900 04 4
YOUR VIEWS ABOUT YOUR DIABETES
Listed below are a number of symptoms that you may or may not have experienced since your
diabetes. Please indicate by circling Yes or No, whether you have experienced any of these symptoms
since your diabetes, and whether you believe that these symptoms are related to your diabetes.
I have experienced this This symptom is related to my
symptom since my diabetes diabetes
Pain Yes No Yes No
Sore Throat Yes No Yes No
Nausea Yes No Yes No
Breathlessness Yes No Yes No
Weight Loss Yes No Yes No
Fatigue Yes No Yes No
Stiff Joints Yes No Yes No
Sore Eyes Yes No Yes No
Wheeziness Yes No Yes No
Headaches Yes No Yes No
Upset Stomach Yes No Yes No
Sleep Difficulties Yes No Yes No
Dizziness Yes No Yes No
Loss of Strength Yes No Yes No
We are interested in your own personal views of how you now see your current diabetes.
Please indicate how much you agree or disagree with the following statements about your diabetes by
ticking the appropriate box.








My diabetes will last a short time
ip2
My diabetes is likely to be permanent rather
than temporary
1p3
My diabetes will last for a long time







IP4* This diabetes will pass quickly
IP5* I expect to have this diabetes for the rest of
my life
IP6
My diabetes is a serious condition
IP7
My diabetes has major consequences on my
life
IP8*
My diabetes does not have much effect on my
life
IP9
My diabetes strongly affects the way others
see me
IP10
My diabetes has serious financial
consequences
IP11
My diabetes causes difficulties for those who
are close to me
IP 12 There is a lot which I can do to control my
symptoms
IP13 What I do can determine whether my diabetes
gets better or worse
IP14 The course of my diabetes depends on me
IP15*
Nothing I do will affect my diabetes
IP16 I have the power to influence my diabetes
IP17*
My actions will have no affect on the outcome
of my diabetes
IP18*
My diabetes will improve in time
IP19*
There is very little that can be done to
improve my diabetes
1P20
My treatment will be effective in curing my
diabetes
IP21 The negative effects of my diabetes can be
prevented (avoided) by my treatment
IP22
My treatment can control my diabetes
IP23* There is nothing which can help my condition
IP24 The symptoms of my condition are puzzling to
me
IP25
My diabetes is a mystery to me
IP26 I don*understand my diabetes
IP27
My diabetes doesn=fcmake any sense to me
IP28* I have a clear picture or understanding of my
condition
IP29 The symptoms of my diabetes change a great
deal from day to day
IP30
My symptoms come and go in cycles
IP31
My diabetes is very unpredictable
IP32 I go through cycles in which my diabetes gets
better and worse.
IP33 I get depressed when I think about my
diabetes
IP34 When I think about my diabetes I get upset
IP35
My diabetes makes me feel angry
IP36*
My diabetes does not worry me
IP37
Having this diabetes makes me feel anxious
IP38
My diabetes makes me feel afraid
CAUSES OF MY DIABETES
We are interested in what you consider may have been the cause of your diabetes. As people are very
different, there is no correct answer for this question. We are most interested in your own views about the
factors that caused your diabetes rather than what others including doctors or family may have suggested to
you. Below is a list of possible causes for your diabetes. Please indicate how much you agree or disagree that







CI Stress or worry
C2 Hereditary - it runs in my family
C3 A Germ or virus
C4
Diet or eating habits
C5 Chance or bad luck
C6 Poor medical care in my past




My mental attitude e.g. thinking about life
negatively
CIO
Family problems or worries
Cll* Overwork
CI 2*










In the table below, please list in rank-order the three most important factors that you now believe caused
YOUR diabetes. You may use any of the items from the box above, or you may have additional ideas of your
own.




YOUR VIEWS ABOUT YOUR PATIENTS' DIABETES
We are interested in your views of how you see your patients' diabetes.
Please indicate how much you agree or disagree with the following statements1











1 The patients' diabetes is a serious
condition
2 The patients' diabetes has major
consequences on his/her life
3 The patients' diabetes does not
have much effect on his/her life
4 The patients' diabetes strongly
affects the way others see them
5 The patients' diabetes has serious
financial consequences
6 The patients' diabetes causes
difficulties for those who are close
to him/her
7 There is a lot that the patient can
do to control his/her symptoms
8 What the patient does can
determine whether the diabetes
gets better or worse
9 The course of the patients' diabetes
depends on him/her
10 Nothing the patient does will affect
their diabetes
11 The patient has the power to
influence his/her diabetes
12 The patients' actions will have no
affect on the outcome of their
diabetes
13 There is very little that can be done
to improve the patients' diabetes
14 Treatment will be effective in
curing the patients' diabetes
15 The negative effects of the
patients' diabetes can be avoided
by treatment
16 There is nothing which can help
the patients' condition
1
Adapted from the Illness Perceptions Questionnaire - Revised (IPQ-R)
